<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="clc70153" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Cardiol</journal-id><journal-id journal-id-type="iso-abbrev">Clin Cardiol</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1932-8737</journal-id><journal-id journal-id-type="publisher-id">CLC</journal-id><journal-title-group><journal-title>Clinical Cardiology</journal-title></journal-title-group><issn pub-type="ppub">0160-9289</issn><issn pub-type="epub">1932-8737</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40405445</article-id><article-id pub-id-type="pmc">PMC12098307</article-id><article-id pub-id-type="doi">10.1002/clc.70153</article-id><article-id pub-id-type="publisher-id">CLC70153</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>A Comprehensive Review of Two&#x02010;Dimensional Speckle&#x02010;Tracking Echocardiography in Assessing Right and Left Ventricular Function in Diabetic Patients</article-title></title-group><contrib-group><contrib id="clc70153-cr-0001" contrib-type="author"><name><surname>Alizadehasl</surname><given-names>Azin</given-names></name><xref rid="clc70153-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="clc70153-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="clc70153-cr-0002" contrib-type="author"><name><surname>Mokhayeri</surname><given-names>Mahshid</given-names></name><xref rid="clc70153-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="clc70153-cr-0003" contrib-type="author"><name><surname>Sohani</surname><given-names>Zeynab</given-names></name><xref rid="clc70153-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="clc70153-cr-0004" contrib-type="author" corresp="yes"><name><surname>Zamanian</surname><given-names>Mohammad Yasin</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0944-0320</contrib-id><xref rid="clc70153-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="clc70153-aff-0004" ref-type="aff">
<sup>4</sup>
</xref><address><email>m.zamanian@umsha.ac.ir</email><email>mzamaniyan66@yahoo.com</email></address></contrib><contrib id="clc70153-cr-0005" contrib-type="author"><name><surname>Shahbazi</surname><given-names>Parai</given-names></name><xref rid="clc70153-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="clc70153-cr-0006" contrib-type="author" corresp="yes"><name><surname>Borzouei</surname><given-names>Shiva</given-names></name><xref rid="clc70153-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><address><email>borzooeishiva@yahoo.com</email></address></contrib></contrib-group><aff id="clc70153-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Cardio&#x02010;Oncology Research Center, Rajaie Cardiovascular Medical and Research Center</named-content>
<institution>Iran University of Medical Sciences</institution>
<city>Tehran</city>
<country country="IR">Iran</country>
</aff><aff id="clc70153-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Echocardiography Research Center, Rajaie Cardiovascular Medical and Research Center</named-content>
<institution>Iran University of Medical Sciences</institution>
<city>Tehran</city>
<country country="IR">Iran</country>
</aff><aff id="clc70153-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Endocrinology, School of Medicine</named-content>
<institution>Hamadan University of Medical Science</institution>
<city>Hamadan</city>
<country country="IR">Iran</country>
</aff><aff id="clc70153-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Physiology, School of Medicine</named-content>
<institution>Hamadan University of Medical Sciences</institution>
<city>Hamadan</city>
<country country="IR">Iran</country>
</aff><aff id="clc70153-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Cardiology, School of Medicine</named-content>
<institution>Hamadan University of Medical Sciences</institution>
<city>Hamadan</city>
<country country="IR">Iran</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold> Mohammad Yasin Zamanian (<email>m.zamanian@umsha.ac.ir</email>; <email>mzamaniyan66@yahoo.com</email>)<break/>
Shiva Borzouei (<email>borzooeishiva@yahoo.com</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2025</year></pub-date><volume>48</volume><issue seq="20">5</issue><issue-id pub-id-type="doi">10.1002/clc.v48.5</issue-id><elocation-id>e70153</elocation-id><history>
<date date-type="rev-recd"><day>28</day><month>4</month><year>2025</year></date>
<date date-type="received"><day>26</day><month>2</month><year>2025</year></date>
<date date-type="accepted"><day>07</day><month>5</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 The Author(s). Clinical Cardiology published by Wiley Periodicals, LLC.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Clinical Cardiology</italic> published by Wiley Periodicals, LLC.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:CLC-48-e70153.pdf"/><abstract><title>ABSTRACT</title><sec id="clc70153-sec-0010"><title>Background</title><p>Two&#x02010;dimensional speckle&#x02010;tracking echocardiography (2D&#x02010;STE) has emerged as a valuable tool for assessing cardiac function in patients with type 1 (T1DM) and type 2 diabetes mellitus (T2DM).</p></sec><sec id="clc70153-sec-0020"><title>Hypothesis</title><p>This review synthesizes recent studies utilizing 2D&#x02010;STE in diabetic patients, highlighting its clinical applications and findings.</p></sec><sec id="clc70153-sec-0030"><title>Methods</title><p>In this review, relevant studies were identified through comprehensive searches of major scientific databases, including PubMed, Scopus, Google Scholar, ScienceDirect, and other reputable sources.</p></sec><sec id="clc70153-sec-0040"><title>Results</title><p>The results of this study indicate that 2D&#x02010;STE is capable of detecting subclinical cardiac dysfunction in patients with both T1DM and T2DM, even in instances where conventional echocardiographic parameters appear to be within normal limits. Assessment of right ventricular (RV) function through 2D&#x02010;STE has demonstrated impaired right ventricular free wall longitudinal strain (RVFWLS) and global longitudinal strain (RVGLS) in individuals with T2DM, which correlates with suboptimal glycemic control. Furthermore, evaluation of left ventricular (LV) function has revealed decreased global longitudinal strain (GLS) and impaired LV twist mechanics in T2DM patients, particularly under conditions of physiological stress.</p><p>In T1DM patients, 2D&#x02010;STE has identified early changes in myocardial deformation, with studies reporting reduced LV and RV strain values compared to healthy controls. The technique has also been effective in assessing the impact of disease duration and glycemic control on cardiac function in both T1DM and T2DM.</p></sec><sec id="clc70153-sec-0050"><title>Conclusions</title><p>These findings underscore the potential of 2D&#x02010;STE as a sensitive and comprehensive tool for early detection of cardiac dysfunction in both T1DM and T2DM, potentially guiding management strategies and improving outcomes in these high&#x02010;risk populations.</p></sec></abstract><abstract abstract-type="graphical"><p>This figure illustrates the application of 2D speckle&#x02010;tracking echocardiography (2D&#x02010;STE) in assessing cardiac function in diabetes patients. At the center, a detailed anatomical representation of the heart is shown, highlighting the areas that can be evaluated using this advanced imaging technique. The left side of the image explains that 2D&#x02010;STE can detect subclinical cardiac dysfunction before overt clinical manifestations appear in type 2 diabetes mellitus (T2DM) patients. The figure also demonstrates that 2D&#x02010;STE shows impaired left atrial function in poorly controlled T2DM patients with coronary artery disease, as well as in those with nonalcoholic fatty liver disease (NAFLD). On the right side, the image includes a human figure representing a T2DM patient, with an illustration suggesting cellular&#x02010;level changes. The bottom right corner shows the 2D&#x02010;STE equipment used for these cardiac assessments, indicating its role in evaluating both left ventricular (LV) and right ventricular (RV) function comprehensively in diabetes patients.<boxed-text position="anchor" content-type="graphic"><graphic xlink:href="CLC-48-e70153-g001.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p></abstract><kwd-group><kwd id="clc70153-kwd-0001">diabetes mellitus</kwd><kwd id="clc70153-kwd-0002">echocardiography</kwd><kwd id="clc70153-kwd-0003">HbA1c</kwd><kwd id="clc70153-kwd-0004">left ventricular</kwd><kwd id="clc70153-kwd-0005">right ventricular</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>The authors received no specific funding for this work.</funding-source></award-group></funding-group><counts><fig-count count="1"/><table-count count="2"/><page-count count="13"/><word-count count="10278"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.6 mode:remove_FC converted:23.05.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="clc70153-sec-0060"><label>1</label><title>Introduction</title><p>Two&#x02010;dimensional speckle&#x02010;tracking echocardiography (2D&#x02010;STE) has emerged as a powerful tool for assessing cardiac function in various cardiovascular conditions, including diabetes mellitus (DM) [<xref rid="clc70153-bib-0001" ref-type="bibr">1</xref>, <xref rid="clc70153-bib-0002" ref-type="bibr">2</xref>]. DM is a chronic metabolic disorder characterized by elevated blood glucose levels, which can lead to significant cardiovascular complications over time [<xref rid="clc70153-bib-0003" ref-type="bibr">3</xref>, <xref rid="clc70153-bib-0004" ref-type="bibr">4</xref>]. The impact of DM on cardiac function is multifaceted, affecting both the left and right ventricles through various mechanisms, including metabolic disturbances, microvascular dysfunction, and autonomic neuropathy [<xref rid="clc70153-bib-0005" ref-type="bibr">5</xref>, <xref rid="clc70153-bib-0006" ref-type="bibr">6</xref>]. Traditional echocardiographic parameters, such as ejection fraction (EF), have limitations in detecting subtle changes in cardiac function, particularly in the early stages of diabetic cardiomyopathy [<xref rid="clc70153-bib-0007" ref-type="bibr">7</xref>, <xref rid="clc70153-bib-0008" ref-type="bibr">8</xref>]. 2D&#x02010;STE offers a more sensitive and comprehensive assessment of myocardial deformation, allowing for the detection of subclinical cardiac dysfunction before overt clinical manifestations [<xref rid="clc70153-bib-0008" ref-type="bibr">8</xref>]. This technique analyzes the movement of speckles within the myocardium throughout the cardiac cycle, providing quantitative measures of myocardial strain and strain rate [<xref rid="clc70153-bib-0009" ref-type="bibr">9</xref>]. In patients with DM, 2D&#x02010;STE has shown promise in identifying early changes in left ventricular (LV) function, even in those with preserved EF [<xref rid="clc70153-bib-0001" ref-type="bibr">1</xref>]. The assessment of global longitudinal strain (GLS) using 2D&#x02010;STE has been particularly valuable in detecting subtle LV dysfunction in diabetic patients [<xref rid="clc70153-bib-0010" ref-type="bibr">10</xref>]. Moreover, 2D&#x02010;STE has demonstrated utility in evaluating right ventricular (RV) function, which is often overlooked but can be significantly affected in DM [<xref rid="clc70153-bib-0002" ref-type="bibr">2</xref>]. RV dysfunction in DM can occur independently of LV dysfunction and may contribute to the overall cardiovascular risk in these patients [<xref rid="clc70153-bib-0010" ref-type="bibr">10</xref>]. The ability of 2D&#x02010;STE to assess both LV and RV function comprehensively makes it a valuable tool in the management of diabetic patients.</p><p>Early detection of cardiac dysfunction using 2D&#x02010;STE may allow for timely interventions and potentially improve outcomes in individuals with DM [<xref rid="clc70153-bib-0011" ref-type="bibr">11</xref>]. Furthermore, 2D&#x02010;STE has shown potential in monitoring the effects of various treatments, including glucose&#x02010;lowering medications and exercise interventions, on cardiac function in diabetic patients [<xref rid="clc70153-bib-0008" ref-type="bibr">8</xref>]. The technique's reproducibility and relatively low operator dependence make it suitable for longitudinal follow&#x02010;up of cardiac function in DM [<xref rid="clc70153-bib-0012" ref-type="bibr">12</xref>]. Recent studies have also explored the prognostic value of 2D&#x02010;STE&#x02010;derived parameters in predicting cardiovascular events in diabetic populations [<xref rid="clc70153-bib-0010" ref-type="bibr">10</xref>, <xref rid="clc70153-bib-0013" ref-type="bibr">13</xref>]. The integration of 2D&#x02010;STE into routine clinical practice for diabetic patients could potentially enhance risk stratification and guide personalized management strategies. However, standardization of 2D&#x02010;STE protocols and establishment of normative values specific to diabetic populations are needed to optimize its clinical application. Additionally, the cost&#x02010;effectiveness and widespread availability of 2D&#x02010;STE in different healthcare settings remain important considerations for its broader implementation [<xref rid="clc70153-bib-0001" ref-type="bibr">1</xref>, <xref rid="clc70153-bib-0013" ref-type="bibr">13</xref>]. Despite these challenges, the growing body of evidence supporting the use of 2D&#x02010;STE in assessing cardiac function in DM highlights its potential as a valuable clinical tool [<xref rid="clc70153-bib-0001" ref-type="bibr">1</xref>]. As research in this field continues to evolve, 2D&#x02010;STE may play an increasingly important role in the comprehensive cardiovascular evaluation of individuals with DM. In this review, relevant studies were identified through comprehensive searches of major scientific databases, including PubMed, Google Scholar, ScienceDirect, and other reputable sources. The search strategy involved using specific keywords related to 2D&#x02010;STE, DM, and cardiac function. Studies were selected based on their relevance to the assessment of cardiac function in patients with type 1 and type 2 diabetes mellitus using 2D&#x02010;STE. Additional inclusion criteria included original research articles in English. The titles and abstracts of retrieved articles were screened, and full texts were reviewed for eligibility. Reference lists of selected articles were also examined to identify further relevant studies. Data extraction focused on study design, population characteristics, echocardiographic techniques, and key findings related to 2D&#x02010;STE parameters in diabetic patients.</p><p>The aim of this review article is to critically evaluate the current literature on the use of 2D&#x02010;STE echocardiography in assessing right and LV function in individuals with DM, highlighting its clinical applications, advantages, and limitations.</p></sec><sec id="clc70153-sec-0070"><label>2</label><title>Overview of 2D&#x02010;STE</title><p>2D&#x02010;STE emerged in the early 2000s as an extension of tissue Doppler imaging techniques. It was developed to overcome limitations of earlier methods, particularly angle dependency in assessing myocardial motion. The technique utilizes natural acoustic markers, or speckles, within the myocardium to track myocardial deformation throughout the cardiac cycle [<xref rid="clc70153-bib-0014" ref-type="bibr">14</xref>, <xref rid="clc70153-bib-0015" ref-type="bibr">15</xref>].</p><p>This noninvasive imaging modality utilizes the natural acoustic markers, or speckles, within the myocardium to track myocardial deformation throughout the cardiac cycle. 2D&#x02010;STE provides quantitative measurements of myocardial strain and strain rate, offering a more comprehensive evaluation of cardiac mechanics compared to traditional echocardiographic parameters [<xref rid="clc70153-bib-0016" ref-type="bibr">16</xref>, <xref rid="clc70153-bib-0017" ref-type="bibr">17</xref>].</p><p>The technique allows for the assessment of both global and regional myocardial function, making it particularly valuable in detecting subtle changes in cardiac performance [<xref rid="clc70153-bib-0015" ref-type="bibr">15</xref>, <xref rid="clc70153-bib-0018" ref-type="bibr">18</xref>]. One of the key advantages of 2D&#x02010;STE is its ability to analyze myocardial deformation in multiple directions, including longitudinal, circumferential, and radial strains. This multi&#x02010;directional analysis provides a more complete picture of myocardial function and can reveal abnormalities that may not be apparent with conventional echocardiography [<xref rid="clc70153-bib-0019" ref-type="bibr">19</xref>, <xref rid="clc70153-bib-0020" ref-type="bibr">20</xref>].</p><p>2D&#x02010;STE has shown particular promise in the evaluation of LV function, with GLS emerging as a robust marker of overall LV systolic function [<xref rid="clc70153-bib-0021" ref-type="bibr">21</xref>].</p><p>In patients with preserved EF, 2D&#x02010;STE can detect subclinical LV dysfunction, making it a valuable tool for early diagnosis of various cardiac conditions [<xref rid="clc70153-bib-0021" ref-type="bibr">21</xref>]. The technique has also demonstrated utility in assessing RV function, which is often challenging to evaluate using traditional echocardiographic methods [<xref rid="clc70153-bib-0022" ref-type="bibr">22</xref>].</p><p>RV free wall strain and RV four&#x02010;chamber longitudinal strain are two key parameters derived from 2D&#x02010;STE that provide insights into RV performance [<xref rid="clc70153-bib-0023" ref-type="bibr">23</xref>].</p><p>2D&#x02010;STE has found applications across a wide range of cardiovascular conditions, including ischemic heart disease, cardiomyopathies, and valvular heart disease. In the field of congenital heart disease, 2D&#x02010;STE has proven valuable in assessing ventricular function in pediatric patients, offering a more sensitive approach than conventional methods [<xref rid="clc70153-bib-0024" ref-type="bibr">24</xref>].</p><p>The technique has also been applied to evaluate cardiac function in various systemic diseases that can affect the heart, such as beta&#x02010;thalassemia major [<xref rid="clc70153-bib-0016" ref-type="bibr">16</xref>].</p><p>One of the strengths of 2D&#x02010;STE is its relatively low operator dependence and good reproducibility, making it suitable for longitudinal follow&#x02010;up of patients. The technique has shown promise in monitoring the effects of various interventions, including medical therapies and cardiac rehabilitation programs [<xref rid="clc70153-bib-0025" ref-type="bibr">25</xref>].</p><p>In sports cardiology, 2D&#x02010;STE has been used to assess the impact of different levels of exercise on myocardial performance, helping to distinguish between physiological adaptations and pathological changes [<xref rid="clc70153-bib-0025" ref-type="bibr">25</xref>].</p><p>Despite its many advantages, 2D&#x02010;STE does have some limitations, including dependence on image quality and the need for standardization across different ultrasound systems and software platforms [<xref rid="clc70153-bib-0014" ref-type="bibr">14</xref>, <xref rid="clc70153-bib-0026" ref-type="bibr">26</xref>].</p><p>Ongoing research is focused on addressing these challenges and further refining the technique. As 2D&#x02010;STE continues to evolve, it is increasingly being integrated into routine clinical practice, complementing traditional echocardiographic assessments and providing additional diagnostic and prognostic information. The growing body of evidence supporting the use of 2D&#x02010;STE in various cardiac conditions underscores its potential to become a standard tool in comprehensive cardiovascular evaluation.</p></sec><sec id="clc70153-sec-0080"><label>3</label><title>Recent Developments</title><p>In recent years, 2D&#x02010;STE has been increasingly used for:</p><p>Endocrine disorders: Detecting subclinical LV dysfunction in patients with acromegaly [<xref rid="clc70153-bib-0027" ref-type="bibr">27</xref>, <xref rid="clc70153-bib-0028" ref-type="bibr">28</xref>].</p><p>Cardiotoxicity monitoring: Detecting early signs of cardiac dysfunction in cancer patients undergoing chemotherapy [<xref rid="clc70153-bib-0029" ref-type="bibr">29</xref>, <xref rid="clc70153-bib-0030" ref-type="bibr">30</xref>].</p><p>Thyroid disorders: Assessing cardiac contractility in patients with subclinical hyperthyroidism [<xref rid="clc70153-bib-0031" ref-type="bibr">31</xref>].</p></sec><sec id="clc70153-sec-0090"><label>4</label><title>Using the 2D&#x02010;STE to Assess Right and Left Ventricular Function in Patients With Type 2 Diabetes Mellitus (T2DM)</title><p>2D&#x02010;STE has emerged as a powerful tool for assessing myocardial function in patients with T2DM. This advanced echocardiographic technique allows for the quantitative evaluation of both left and right ventricular function by tracking the motion of speckles in the myocardium throughout the cardiac cycle. 2D&#x02010;STE offers several advantages over conventional echocardiographic parameters in evaluating cardiac function in T2DM patients. It provides a more sensitive and accurate assessment of subtle myocardial changes, allowing for the detection of subclinical dysfunction before overt clinical manifestations. This is particularly important in T2DM patients, where early identification of cardiac abnormalities can guide timely interventions and potentially improve outcomes.</p><p>For LV assessment, 2D&#x02010;STE enables the measurement of global and regional longitudinal, circumferential, and radial strain, offering a comprehensive evaluation of LV mechanics. In T2DM patients, LV longitudinal strain has been shown to be impaired even in the presence of normal EF, indicating its value in detecting early diabetic cardiomyopathy.</p><p>RV function assessment, traditionally challenging due to its complex geometry, has been significantly improved with 2D&#x02010;STE. The technique allows for the evaluation of RV free wall and septal strain, providing insights into RV mechanics that were previously difficult to obtain.</p><p>Recent studies have demonstrated that RV dysfunction, as assessed by 2D&#x02010;STE, is present in T2DM patients and may have prognostic implications.</p><p>By utilizing 2D&#x02010;STE for both LV and RV assessment in T2DM patients, clinicians can gain a more comprehensive understanding of cardiac function, potentially leading to earlier detection of diabetic cardiomyopathy and improved management strategies.</p><p>This introduction sets the stage for a detailed exploration of the application and significance of 2D&#x02010;STE in evaluating biventricular function in T2DM patients.</p><p>HbA1c or glycated hemoglobin, is a critical marker used to assess long&#x02010;term blood glucose control in individuals, particularly those with diabetes [<xref rid="clc70153-bib-0032" ref-type="bibr">32</xref>].</p><p>The relationship between HbA1c levels and RV free wall longitudinal strain (RVFWLS) is significant in the context of T2DM [<xref rid="clc70153-bib-0002" ref-type="bibr">2</xref>]. Higher HbA1c levels are independently associated with subclinical RV dysfunction, indicating that poor glycemic control adversely affects RV performance. Specifically, RVFWLS is a sensitive measure that reflects the impact of hyperglycemia on the RV myocardium [<xref rid="clc70153-bib-0002" ref-type="bibr">2</xref>].</p><p>Zhang et al. investigated the association between glycemic control and RV function in individuals with T2DM using 2D&#x02010;STE and three&#x02010;dimensional echocardiography (3DE). The study results revealed that patients with uncontrolled T2DM exhibited reduced RVFWLS compared to those with controlled blood glucose levels. This reduction in RVFWLS was more pronounced in the uncontrolled subgroup, indicating a significant impact of poor glycemic control on RV function. Additionally, the uncontrolled T2DM subgroup showed higher pulmonary artery systolic pressure (PASP) and a lower RVFWLS/PASP ratio, suggesting increased RV afterload. The incidence of RV dysfunction was significantly higher in the uncontrolled T2DM patients compared to the controlled subgroup. Furthermore, the study demonstrated an impaired right ventricular&#x02010;pulmonary circulation (RV&#x02010;PC) coupling in diabetes, highlighting the importance of effective glycemic control for preventing diabetic cardiomyopathy. These findings underscore the critical role of maintaining controlled blood glucose levels to mitigate cardiovascular complications in T2DM patients [<xref rid="clc70153-bib-0002" ref-type="bibr">2</xref>].</p><p>RVGLS has emerged as a key parameter for assessing the systolic function of the RV, offering several advantages over conventional echocardiographic measures [<xref rid="clc70153-bib-0033" ref-type="bibr">33</xref>]. It is angle&#x02010;independent, less load&#x02010;dependent than other parameters, and highly accurate for measuring regional myocardial deformation, allowing for the detection of subclinical RV dysfunction even when conventional parameters appear normal [<xref rid="clc70153-bib-0033" ref-type="bibr">33</xref>]. RVGLS has demonstrated strong prognostic value across various cardiovascular conditions, including pulmonary hypertension, heart failure (HF), and cardiac amyloidosis [<xref rid="clc70153-bib-0034" ref-type="bibr">34</xref>, <xref rid="clc70153-bib-0035" ref-type="bibr">35</xref>, <xref rid="clc70153-bib-0036" ref-type="bibr">36</xref>]. Studies have shown that RVGLS correlates better with cardiac MRI&#x02010;derived RV EF compared to parameters like tricuspid annular plane systolic excursion (TAPSE) or fractional area change (FAC), and provides incremental prognostic information beyond LV EF in HF patients [<xref rid="clc70153-bib-0034" ref-type="bibr">34</xref>, <xref rid="clc70153-bib-0037" ref-type="bibr">37</xref>].</p><p>Wu et al. utilized 2D&#x02010;STE to assess RV systolic function in individuals with prediabetes and T2DM. Results indicated that the RVGLS and RV free wall strain (RVFW&#x02010;LS) decreased progressively from normoglycemic controls to prediabetic and diabetic patients. This decline in strain values suggests early impairment of RV systolic function in patients with abnormal glucose metabolism. The study found that 2D&#x02010;STE was more sensitive than conventional echocardiography in detecting these subtle changes. Multivariate regression analysis identified HbA1c, interventricular septal longitudinal strain (IVS&#x02010;LS), and LV end&#x02010;diastolic diameter (LVEDd) as independent predictors of RVGLS. The findings highlight the potential of 2D&#x02010;STE in identifying early cardiac dysfunction, which might not be evident through conventional methods. Overall, the study underscores the importance of monitoring glucose levels to mitigate myocardial damage [<xref rid="clc70153-bib-0010" ref-type="bibr">10</xref>].</p><p>Epicardial adipose tissue (EAT) is a unique fat depot located between the myocardium and visceral pericardium, sharing the same microcirculation as the adjacent myocardium [<xref rid="clc70153-bib-0038" ref-type="bibr">38</xref>, <xref rid="clc70153-bib-0039" ref-type="bibr">39</xref>]. Under normal physiological conditions, EAT serves protective functions, including acting as a buffer against mechanical stress, providing thermal regulation, and serving as a local energy source for the heart [<xref rid="clc70153-bib-0038" ref-type="bibr">38</xref>]. However, in pathological states, particularly in patients with T2DM, increased EAT thickness has been associated with adverse cardiovascular outcomes [<xref rid="clc70153-bib-0040" ref-type="bibr">40</xref>]. Studies have shown that patients with T2DM tend to have higher EAT volume compared to nondiabetic individuals, and this increased EAT is linked to a higher risk of coronary artery disease (CAD), metabolic syndrome, and overall cardiovascular morbidity and mortality [<xref rid="clc70153-bib-0041" ref-type="bibr">41</xref>, <xref rid="clc70153-bib-0042" ref-type="bibr">42</xref>].</p><p>Systolic blood pressure (SBP) and HbA1c levels are crucial clinical parameters in the management of patients with T2DM. Studies have identified specific threshold effects between albumin/creatinine ratio (ACR) and both HbA1c and SBP, with risk threshold values of HbA1c&#x02009;=&#x02009;6.4% and SBP&#x02009;=&#x02009;127&#x02009;mmHg, respectively, above which the logarithm function (LnACR) increased dramatically [<xref rid="clc70153-bib-0043" ref-type="bibr">43</xref>]. Higher levels of HbA1c have been associated with an increased risk of hypertension (HT), even after adjusting for various confounding factors, suggesting a potential causal relationship between glycemic control and blood pressure regulation [<xref rid="clc70153-bib-0044" ref-type="bibr">44</xref>]. Furthermore, long&#x02010;term visit&#x02010;to&#x02010;visit variability in both HbA1c and SBP has been shown to represent a combined and additive risk for cardiovascular disease (CVD) incidence in patients with T2DM, with a possible synergistic effect between HbA1c variability and mean SBP levels [<xref rid="clc70153-bib-0045" ref-type="bibr">45</xref>].</p><p>Song et al. utilized 2D&#x02010;STE to assess RV function in patients with T2DM. The study found that EAT thickness was significantly higher in patients with T2DM compared to nondiabetic controls. In T2DM patients, those with EAT thickness of 5&#x02009;mm or more exhibited more pronounced RV dysfunction. Specifically, the right ventricular longitudinal strain (RV&#x02010;LS) and early&#x02010;diastole longitudinal strain rate (RV LSR&#x02010;E) were significantly lower in T2DM patients with thicker EAT. The study demonstrated that EAT was negatively correlated with RV LS and RV LSR&#x02010;E, independent of other cardiovascular risk factors such as SBP and HbA1c levels. These findings suggest that increased EAT is associated with subclinical RV systolic and early diastolic dysfunction in T2DM patients. The use of 2D&#x02010;STE was effective in detecting these subtle myocardial dysfunctions. Overall, the study highlights the potential role of EAT as a cardiovascular risk factor in T2DM, warranting further investigation and potential therapeutic targeting.</p><p>Song et al. utilized 2D&#x02010;STE to assess the relationship between EAT and LV function in patients with T2DM. The results indicated that patients with a GLS of less than 18% exhibited higher age, body mass index (BMI), waist circumference (WC), SBP, diastolic blood pressure (DBP), low&#x02010;density lipoprotein cholesterol (LDL&#x02010;C), HbA1c, E/e ratio, and EAT thickness compared to those with GLS of 18% or more. The study found no significant differences in other echocardiographic parameters such as left atrial diameter (LAD), interventricular septal thickness (IVSD), LV posterior wall thickness (LVPWD), LVEDD, LV end&#x02010;systolic diameter (LVESD), and LV ejection fraction (LVEF) between the two groups. Multivariate linear regression analysis revealed that EAT thickness was independently associated with both systolic and diastolic dysfunction of the left ventricle in T2DM patients. The study demonstrated good reliability in the measurement of GLS, EAT, and E/e, with an intra&#x02010;class correlation coefficient (ICC) of 0.75 or higher. The findings suggest that thickened EAT is linked to impaired LV function in T2DM patients. This association underscores the potential of EAT as a therapeutic target for improving cardiac function in this population.</p><p>Nonalcoholic fatty liver disease (NAFLD) is increasingly recognized as the most common chronic liver disease among patients with T2DM [<xref rid="clc70153-bib-0046" ref-type="bibr">46</xref>]. The diagnosis rate of NAFLD is rising, and T2DM patients are at a higher risk of developing severe forms of this condition [<xref rid="clc70153-bib-0047" ref-type="bibr">47</xref>]. Furthermore, NAFLD can lead to CVDs, highlighting the importance of monitoring cardiac function in these patients.</p><p>Chang et al. utilized 2D&#x02010;STE to evaluate LA function in patients with T2DM and NAFLD. It found that patients with moderate to severe NAFLD exhibited significant changes in LA function compared to those with mild or no fatty liver disease. Specifically, the LA active ejection fraction (LAAEF) and late diastolic strain rates (LASRa) were significantly higher in patients with severe NAFLD. Conversely, the LA passive ejection fraction (LAPEF), SRes, and systolic strain rates (LASRs) were notably decreased in this group. These findings suggest that as NAFLD severity increases, there are marked alterations in LA function, potentially indicating early cardiac dysfunction. The study underscores the importance of monitoring cardiac function in T2DM patients with NAFLD, as early changes in LA function could serve as an indicator for intervention and management. Overall, 2D&#x02010;STE proved to be a valuable noninvasive tool for detecting early changes in LA function in this patient population [<xref rid="clc70153-bib-0012" ref-type="bibr">12</xref>].</p><p>Global peak systolic longitudinal rotation (PSLR) is a sensitive measure of LV systolic function that can detect subclinical LV dysfunction even when conventional parameters like EF appear normal [<xref rid="clc70153-bib-0037" ref-type="bibr">37</xref>, <xref rid="clc70153-bib-0048" ref-type="bibr">48</xref>]. Importantly, HbA1c levels have been found to negatively correlate with apex and global PSLR in T2DM patients, indicating that those with higher HbA1c values demonstrate larger clockwise apex and global PSLR [<xref rid="clc70153-bib-0048" ref-type="bibr">48</xref>]. This relationship suggests that PSLR could serve as a sensitive indicator of LV systolic dysfunction in T2DM patients, potentially reflecting the impact of poor glycemic control on cardiac function [<xref rid="clc70153-bib-0048" ref-type="bibr">48</xref>, <xref rid="clc70153-bib-0049" ref-type="bibr">49</xref>].</p><p>Huang et al. investigated the use of 2D&#x02010;STE to assess LV systolic dysfunction in patients with T2DM. It found that T2DM patients exhibited a significant clockwise PSLR, whereas normal subjects showed minimal PSLR. A negative correlation was observed between HbA1c levels and both apex and global PSLR, indicating that higher HbA1c levels were associated with greater PSLR and impaired cardiac function. The study demonstrated that PSLR could effectively detect LV systolic dysfunction in T2DM patients. The reproducibility and repeatability of PSLR measurements were confirmed, with no significant differences found in interobserver and intraobserver variability. The study concluded that PSLR is a reliable and convenient tool for detecting cardiac dysfunction in T2DM patients. Additionally, HbA1c was identified as a potential predictor of systolic dysfunction in this population [<xref rid="clc70153-bib-0048" ref-type="bibr">48</xref>].</p><p>Dobutamine stress echocardiography (DSE) is a diagnostic imaging technique used to evaluate cardiac function, particularly in patients who are unable to undergo traditional exercise stress testing [<xref rid="clc70153-bib-0050" ref-type="bibr">50</xref>]. During DSE, dobutamine, a medication that stimulates the heart, is administered to increase heart rate and mimic the effects of exercise. This allows for the assessment of myocardial function and the detection of wall motion abnormalities that may not be visible at rest [<xref rid="clc70153-bib-0051" ref-type="bibr">51</xref>].</p><p>DSE is particularly useful in diagnosing CAD and can help reveal subclinical abnormalities in myocardial mechanics, especially in asymptomatic patients with conditions like T2DM. The technique enables clinicians to observe changes in LV function and to assess the heart's response to increased workload, providing valuable information for early diagnosis and management of cardiac conditions [<xref rid="clc70153-bib-0052" ref-type="bibr">52</xref>, <xref rid="clc70153-bib-0053" ref-type="bibr">53</xref>].</p><p>Philouze et al. utilized 2D&#x02010;STE to assess myocardial mechanics in patients with T2DM and control subjects. At rest, there were no significant differences in systolic longitudinal strain (LS) and LS rate between the two groups. However, under dobutamine stress, significant differences emerged, indicating impaired myocardial functional reserve in T2DM patients. Specifically, T2DM patients exhibited reduced apical rotation and twist mechanics compared to controls during stress. These alterations were not apparent at rest, highlighting the utility of stress echocardiography in unmasking subtle myocardial dysfunction. The study also found that EAT was a significant contributor to these stress&#x02010;induced changes. Furthermore, the speckle&#x02010;tracking echocardiographic indexes significantly increased in both groups in response to dobutamine infusion, except for apical rotation, which did not change in the diabetic population. Overall, the results underscore the importance of using stress echocardiography to detect early myocardial dysfunction in asymptomatic T2DM patients [<xref rid="clc70153-bib-0053" ref-type="bibr">53</xref>].</p><p>Fragmented QRS (fQRS) is an electrocardiographic finding characterized by the presence of additional deflections or notches in the QRS complex of the ECG [<xref rid="clc70153-bib-0054" ref-type="bibr">54</xref>]. It is considered a marker of myocardial fibrosis or scar tissue and is associated with an increased risk of cardiovascular adverse events [<xref rid="clc70153-bib-0055" ref-type="bibr">55</xref>]. fQRS can indicate underlying cardiac issues, such as myocardial scarring, and has been linked to various conditions, including diabetic cardiomyopathy, CAD, and HF [<xref rid="clc70153-bib-0056" ref-type="bibr">56</xref>, <xref rid="clc70153-bib-0057" ref-type="bibr">57</xref>].</p><p>Bayramo&#x0011f;lu et al. utilized 2D&#x02010;STE to assess LV function in patients with T2DM and fQRS complexes. The results demonstrated statistically significant differences in LV strain values between patients with and without fQRS, indicating subclinical LV dysfunction in those with fQRS. Specifically, the LV&#x02010;GLS was significantly lower in the fQRS&#x02010;positive group compared to the fQRS&#x02010;negative group. The study identified fQRS and the duration of diabetes as independent predictors of LV&#x02010;GLS, suggesting that fQRS is a reliable marker for detecting early cardiac involvement in diabetic patients. Additionally, the study found that fQRS and minimum left atrial volume index (minLAVI) were independent predictors of the E/SRivr ratio, an index of LV filling pressure. The findings suggest that fQRS could serve as an indicator of diabetic cardiomyopathy, highlighting the potential of STE in evaluating myocardial function in diabetic patients. Overall, the study emphasizes the importance of identifying fQRS in routine clinical assessments to predict better and manage cardiac complications in diabetes [<xref rid="clc70153-bib-0058" ref-type="bibr">58</xref>].</p><p>Early diastolic strain (EDS) and early diastolic strain rate (SRe) are important indices used to assess LA function, providing valuable insights into the heart's diastolic performance [<xref rid="clc70153-bib-0059" ref-type="bibr">59</xref>]. These parameters, measured through advanced echocardiographic techniques such as speckle tracking, offer a more sensitive and accurate evaluation of LA mechanics compared to traditional volumetric measurements [<xref rid="clc70153-bib-0059" ref-type="bibr">59</xref>]. EDS and SRe reflect the LA's ability to expand and receive blood from the pulmonary veins during early ventricular diastole, serving as early indicators of diastolic dysfunction even before overt clinical symptoms manifest [<xref rid="clc70153-bib-0060" ref-type="bibr">60</xref>, <xref rid="clc70153-bib-0061" ref-type="bibr">61</xref>]. Recent studies have demonstrated that impaired EDS and SRe are associated with various cardiovascular conditions, including HT, obesity, and HF, highlighting their potential as prognostic markers in clinical practice [<xref rid="clc70153-bib-0062" ref-type="bibr">62</xref>, <xref rid="clc70153-bib-0063" ref-type="bibr">63</xref>].</p><p>Hosseinsabet et al. utilized 2D&#x02010;STE to assess LA function in CAD patients with varying levels of T2DM control. The results indicated that EDS and SRe, markers of LA conduit function, were significantly lower in CAD patients with poorly controlled diabetes compared to those with well&#x02010;controlled diabetes and euglycemic controls. This impairment in LA function was identified as an independent determinant in patients with poorly controlled diabetes. The study found no significant differences in LA volumetric parameters among the groups, suggesting that the observed functional impairments were not due to changes in atrial size. Multivariable analysis confirmed that poorly controlled diabetes, along with factors like sex and hematocrit, were independent determinants of the impaired indices. The study highlights the importance of glycemic control in preserving cardiac function in diabetic patients with CAD. Overall, the findings underscore the detrimental impact of poor diabetes management on cardiac health, particularly in the context of CAD [<xref rid="clc70153-bib-0064" ref-type="bibr">64</xref>].</p><p>Global peak atrial longitudinal strain (PALS) has emerged as a valuable echocardiographic parameter for assessing LA dysfunction in patients with T2DM and HF. This advanced imaging technique, utilizing speckle tracking echocardiography, provides a more sensitive and accurate evaluation of LA mechanics compared to conventional measures, allowing for earlier detection of subtle changes in atrial function [<xref rid="clc70153-bib-0065" ref-type="bibr">65</xref>]. In patients with T2DM and HF, reduced global PALS values have been associated with worse cardiovascular outcomes and increased risk of atrial fibrillation [<xref rid="clc70153-bib-0065" ref-type="bibr">65</xref>, <xref rid="clc70153-bib-0066" ref-type="bibr">66</xref>].</p><p>Peak atrial contraction strain (PACS) has emerged as a valuable echocardiographic parameter for assessing LA dysfunction in patients with T2DM. This advanced imaging technique, utilizing speckle tracking echocardiography, provides a more sensitive and accurate evaluation of LA contractile function compared to conventional measures, allowing for earlier detection of subtle changes in atrial mechanics [<xref rid="clc70153-bib-0065" ref-type="bibr">65</xref>]. In patients with T2DM, reduced PACS values have been associated with impaired LA booster pump function and increased risk of cardiovascular complications, including atrial fibrillation and HF [<xref rid="clc70153-bib-0065" ref-type="bibr">65</xref>, <xref rid="clc70153-bib-0067" ref-type="bibr">67</xref>]. Recent studies have demonstrated that PACS, along with other LA strain parameters such as PALS, can serve as independent predictors of adverse cardiovascular events in T2DM patients, highlighting their potential as prognostic tools in clinical practice and guiding treatment decisions [<xref rid="clc70153-bib-0065" ref-type="bibr">65</xref>, <xref rid="clc70153-bib-0068" ref-type="bibr">68</xref>].</p><p>Georgievska&#x02010;Ismail et al. investigated the role of 2D&#x02010;STE in assessing LA dysfunction in patients with T2DM and HF with preserved ejection fraction (HFpEF). It found that global PALS and PACS were significantly lower in diabetic patients compared to nondiabetic patients. These reduced strain values were associated with a higher prevalence, greater severity, and longer duration of diabetes. Multiple linear regression analysis identified diabetes as an independent predictor of reduced global PALS and PACS. The study demonstrated that LA strain measurements using 2D&#x02010;STE provided additional value over traditional echocardiographic parameters in detecting LA dysfunction. The inclusion of LA strain parameters significantly improved the discrimination between patients with and without diabetes. Overall, the findings suggest that 2D&#x02010;STE is a valuable tool for early detection of LA dysfunction in diabetic patients with HFpEF [<xref rid="clc70153-bib-0069" ref-type="bibr">69</xref>].</p><p>Left atrial strain parameters provide valuable insights into the mechanical properties and performance of the left atrium during different phases of the cardiac cycle. LA<sub>S&#x02010;S</sub>, or systolic left atrial strain, represents the peak LS of the left atrium during ventricular systole, corresponding to the reservoir function of the LA and measuring its ability to expand and store blood during ventricular contraction. LA<sub>SR&#x02010;S</sub>, or systolic left atrial strain rate, quantifies the rate of deformation of the LA during ventricular systole, providing information about the speed at which the LA expands to accommodate blood flow from the pulmonary veins. L<sub>AS&#x02010;E</sub>, or early diastolic left atrial strain, reflects the LA strain during early ventricular diastole, corresponding to the conduit function of the LA and measuring the passive emptying of the LA as the left ventricle relaxes. Lastly, LA<sub>SR&#x02010;E</sub>, or early diastolic left atrial strain rate, quantifies the rate of LA deformation during early ventricular diastole, indicating how quickly the LA empties passively into the left ventricle [<xref rid="clc70153-bib-0070" ref-type="bibr">70</xref>, <xref rid="clc70153-bib-0071" ref-type="bibr">71</xref>, <xref rid="clc70153-bib-0072" ref-type="bibr">72</xref>].</p><p>Liu et al. utilized 2D&#x02010;STE to assess LA phasic function in patients with HT and T2DM. The results indicated that both the HT group and the HT with diabetes (HT&#x02009;+&#x02009;DM) group exhibited significantly lower peak LA<sub>S&#x02010;S</sub> and LA<sub>SR&#x02010;S</sub> compared to the control group. Specifically, the LA<sub>S&#x02010;E</sub> and LA<sub>SR&#x02010;E</sub>, which reflect early diastolic function, were notably reduced in the HT group and further decreased in the HT&#x02009;+&#x02009;DM group. This suggests that HT impairs LA reservoir and conduit functions, while the presence of diabetes exacerbates the conduit dysfunction. Multivariate regression analysis confirmed that both HT and diabetes independently contributed to the observed reductions in LA<sub>S&#x02010;E</sub> and LA<sub>SR&#x02010;E</sub>. These findings underscore the sensitivity of 2DSTE&#x02010;derived strain and strain rate imaging in detecting subtle changes in LA function associated with these conditions [<xref rid="clc70153-bib-0073" ref-type="bibr">73</xref>].</p><p>Table&#x000a0;<xref rid="clc70153-tbl-0001" ref-type="table">1</xref> summarizes various studies that used 2D&#x02010;STE to assess cardiac function in patients with T2DM and related conditions. It provides details on the total number of participants, the number of T2DM patients, control or other groups, subgroups within the studies, and key results, highlighting the effectiveness of 2D&#x02010;STE in detecting subtle cardiac dysfunctions and the impact of factors such as glycemic control, EAT thickness, and NAFLD on cardiac function in T2DM patients.</p><table-wrap position="float" id="clc70153-tbl-0001" content-type="Table"><label>Table 1</label><caption><p>Summary of studies using 2D&#x02010;STE to assess cardiac function in patients with T2DM.</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><thead valign="bottom"><tr valign="bottom" style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Study</th><th align="center" valign="bottom" rowspan="1" colspan="1">Total participants</th><th align="center" valign="bottom" rowspan="1" colspan="1">T2DM patients</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control/other groups</th><th align="center" valign="bottom" rowspan="1" colspan="1">Subgroups</th><th align="center" valign="bottom" rowspan="1" colspan="1">Key results</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Zhang et al.</td><td align="center" valign="top" rowspan="1" colspan="1">291</td><td align="center" valign="top" rowspan="1" colspan="1">207</td><td align="center" valign="top" rowspan="1" colspan="1">84 NGM</td><td align="center" valign="top" rowspan="1" colspan="1">91 controlled T2DM (HbA1c&#x02009;&#x0003c;&#x02009;7.0%), 116 uncontrolled T2DM (HbA1c&#x02009;&#x02265;&#x02009;7.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">Uncontrolled T2DM patients showed reduced RVFWLS, higher PASP, and lower RVFWLS/PASP ratio compared to controlled T2DM patients.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Wu et al.</td><td align="center" valign="top" rowspan="1" colspan="1">144</td><td align="center" valign="top" rowspan="1" colspan="1">52</td><td align="center" valign="top" rowspan="1" colspan="1">49 NG, 43 PDM</td><td align="center" valign="top" rowspan="1" colspan="1">N/A</td><td align="center" valign="top" rowspan="1" colspan="1">RVGLS and RVFW&#x02010;LS decreased progressively from the NG to the PDM to the T2DM groups. HbA1c, IVS&#x02010;LS, and LVEDd were independent predictors of RVGLS.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Song et al. (EAT study)</td><td align="center" valign="top" rowspan="1" colspan="1">224</td><td align="center" valign="top" rowspan="1" colspan="1">154</td><td align="center" valign="top" rowspan="1" colspan="1">70 non&#x02010;T2DM</td><td align="center" valign="top" rowspan="1" colspan="1">77 T2DM with EAT&#x02009;&#x0003c;&#x02009;5&#x02009;mm, 69 T2DM with EAT&#x02009;&#x02265;&#x02009;5&#x02009;mm</td><td align="center" valign="top" rowspan="1" colspan="1">T2DM patients with EAT&#x02009;&#x02265;&#x02009;5&#x02009;mm showed more pronounced RV dysfunction, with lower RV&#x02010;LS and RV LSR&#x02010;E.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Song et al. (GLS study)</td><td align="center" valign="top" rowspan="1" colspan="1">116</td><td align="center" valign="top" rowspan="1" colspan="1">116</td><td align="center" valign="top" rowspan="1" colspan="1">N/A</td><td align="center" valign="top" rowspan="1" colspan="1">53 with GLS&#x02009;&#x0003c;&#x02009;18%, 63 with GLS&#x02009;&#x02265;&#x02009;18%</td><td align="center" valign="top" rowspan="1" colspan="1">Patients with GLS&#x02009;&#x0003c;&#x02009;18% had higher age, BMI, WC, SBP, DBP, LDL&#x02010;C, HbA1c, E/e ratio, and EAT thickness. EAT thickness was independently associated with LV dysfunction.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chang et al.</td><td align="center" valign="top" rowspan="1" colspan="1">97</td><td align="center" valign="top" rowspan="1" colspan="1">97</td><td align="center" valign="top" rowspan="1" colspan="1">N/A</td><td align="center" valign="top" rowspan="1" colspan="1">Groups A, B, and C based on NAFLD severity</td><td align="center" valign="top" rowspan="1" colspan="1">Patients with moderate to severe NAFLD showed higher LAAEF and LASRa, and lower LAPEF, LASRe, and LASRs.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Huang et al.</td><td align="center" valign="top" rowspan="1" colspan="1">103</td><td align="center" valign="top" rowspan="1" colspan="1">51</td><td align="center" valign="top" rowspan="1" colspan="1">52 normal controls</td><td align="center" valign="top" rowspan="1" colspan="1">N/A</td><td align="center" valign="top" rowspan="1" colspan="1">T2DM patients showed significant clockwise PSLR. HbA1c levels negatively correlated with apex and global PSLR.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Philouze et al.</td><td align="center" valign="top" rowspan="1" colspan="1">79</td><td align="center" valign="top" rowspan="1" colspan="1">44</td><td align="center" valign="top" rowspan="1" colspan="1">35 healthy controls</td><td align="center" valign="top" rowspan="1" colspan="1">N/A</td><td align="center" valign="top" rowspan="1" colspan="1">T2DM patients showed impaired myocardial functional reserve under dobutamine stress, with reduced apical rotation and twist mechanics.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Bayramo&#x0011f;lu et al.</td><td align="center" valign="top" rowspan="1" colspan="1">178</td><td align="center" valign="top" rowspan="1" colspan="1">178</td><td align="center" valign="top" rowspan="1" colspan="1">N/A</td><td align="center" valign="top" rowspan="1" colspan="1">50 fQRS positive, 128 fQRS negative</td><td align="center" valign="top" rowspan="1" colspan="1">fQRS&#x02010;positive group showed lower LV&#x02010;GLS. fQRS and diabetes duration were independent predictors of LV&#x02010;GLS.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hosseinsabet et al.</td><td align="center" valign="top" rowspan="1" colspan="1">110</td><td align="center" valign="top" rowspan="1" colspan="1">66</td><td align="center" valign="top" rowspan="1" colspan="1">44 euglycemic</td><td align="center" valign="top" rowspan="1" colspan="1">33 WCBS, 33 PCBS</td><td align="center" valign="top" rowspan="1" colspan="1">PCBS patients showed lower EDS and SRe compared to WCBS and euglycemic groups.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Georgievska&#x02010;Ismail</td><td align="center" valign="top" rowspan="1" colspan="1">218</td><td align="center" valign="top" rowspan="1" colspan="1">108</td><td align="center" valign="top" rowspan="1" colspan="1">110 non&#x02010;DM HFpEF</td><td align="center" valign="top" rowspan="1" colspan="1">N/A</td><td align="center" valign="top" rowspan="1" colspan="1">49.5% of HFpEF patients had T2DM. The cohort primarily consisted of individuals over 60 years with a high prevalence of cardiovascular risk factors.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Liu et al.</td><td align="center" valign="top" rowspan="1" colspan="1">190</td><td align="center" valign="top" rowspan="1" colspan="1">65</td><td align="center" valign="top" rowspan="1" colspan="1">99 HT, 26 healthy controls</td><td align="center" valign="top" rowspan="1" colspan="1">N/A</td><td align="center" valign="top" rowspan="1" colspan="1">The study compared HT patients with and without T2DM, but specific results were not provided in the given information.</td></tr></tbody></table><table-wrap-foot><fn id="clc70153-tbl1-note-0001"><p>Abbreviations: EAT&#x02009;=&#x02009;epicardial adipose tissue, fQRS&#x02009;=&#x02009;fragmented QRS, GLS&#x02009;=&#x02009;global longitudinal strain, HFpEF&#x02009;=&#x02009;heart failure with preserved ejection fraction, HT&#x02009;=&#x02009;hypertension, NAFLD&#x02009;=&#x02009;nonalcoholic fatty liver disease, NG&#x02009;=&#x02009;normoglycemic, NGM&#x02009;=&#x02009;normal glucose metabolism, PCBS&#x02009;=&#x02009;poorly controlled blood sugar, PDM&#x02009;=&#x02009;prediabetics, WCBS&#x02009;=&#x02009;well&#x02010;controlled blood sugar.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="clc70153-sec-0100"><label>5</label><title>Using the 2D&#x02010;STE to Assess Right and Left Ventricular Function in Patients With Type 1 Diabetes Mellitus (T1DM)</title><p>2D&#x02010;STE has emerged as a powerful tool for evaluating cardiac function in patients with T1DM [<xref rid="clc70153-bib-0074" ref-type="bibr">74</xref>]. This advanced imaging technique allows for the quantitative assessment of myocardial deformation and strain, providing valuable insights into both left and RV mechanics [<xref rid="clc70153-bib-0009" ref-type="bibr">9</xref>, <xref rid="clc70153-bib-0074" ref-type="bibr">74</xref>]. In patients with T1DM, 2D&#x02010;STE can detect subclinical changes in cardiac function before conventional echocardiographic parameters show abnormalities [<xref rid="clc70153-bib-0009" ref-type="bibr">9</xref>]. The ability to identify early cardiac dysfunction is crucial, as it may allow for timely interventions to prevent or delay the progression of diabetic cardiomyopathy [<xref rid="clc70153-bib-0075" ref-type="bibr">75</xref>]. Studies have shown that 2D&#x02010;STE can reveal impaired LV&#x02010;GLS in T1DM patients, even when EF remains normal. This reduction in LV&#x02010;GLS is often one of the earliest signs of diabetic cardiomyopathy and may precede changes in other strain parameters [<xref rid="clc70153-bib-0009" ref-type="bibr">9</xref>, <xref rid="clc70153-bib-0075" ref-type="bibr">75</xref>]. RV function can also be assessed using 2D&#x02010;STE, providing a comprehensive evaluation of cardiac performance in T1DM patients [<xref rid="clc70153-bib-0074" ref-type="bibr">74</xref>]. Research has demonstrated that RVFWLS may be reduced in T1DM patients compared to healthy controls, indicating subclinical RV dysfunction. The assessment of both LV and RV function using 2D&#x02010;STE allows for a more complete understanding of the cardiac effects of T1DM [<xref rid="clc70153-bib-0009" ref-type="bibr">9</xref>].</p><p>These four studies all used 2D&#x02010;STE to assess cardiac function, particularly right and/or LV function, in patients with T1DM. Their common goal was to detect subclinical cardiac dysfunction in T1DM patients using this advanced echocardiographic technique.</p><p>Ahmed et al. utilized 2D&#x02010;STE to assess RV function in young Egyptians with T1DM. It revealed that these patients exhibited significant early RV systolic dysfunction, despite having normal RV and LV ejection fractions. The 2D&#x02010;STE was effective in detecting subclinical cardiac changes, specifically a notable decrease in RV&#x02010;GLS among the diabetic group compared to healthy controls. Additionally, the study found prevalent RV diastolic dysfunction in T1DM patients, with significant differences in echocardiographic parameters such as the E/A and E/Em ratios. The research identified higher BMI and RV E velocity as independent predictors of RV dysfunction, suggesting potential areas for intervention. These findings underscore the importance of early echocardiographic screening in T1DM patients to detect subclinical RV dysfunction. The study highlights the need for timely lifestyle and medical interventions to prevent or delay HF development in this population [<xref rid="clc70153-bib-0074" ref-type="bibr">74</xref>].</p><p>Berceanu et al. utilized 2D&#x02010;STE to evaluate LV and RV function in young adults with DM1. The results indicated that while there were no significant differences in LVEF between the DM1 group and healthy controls, the DM1 group exhibited reduced LS in the LV endocardium and myocardium. Specifically, the GLS for the endocardium and myocardium was significantly lower in the DM1 group compared to controls. Additionally, the study found that mechanical dispersion was higher in the diabetes group, suggesting increased electrical heterogeneity. Despite these differences, RV strain measurements did not show significant differences between the groups. The findings highlight subclinical myocardial dysfunction in DM1 patients, characterized by lower LV endocardial and myocardial strain and higher mechanical dispersion. This suggests that even in the absence of overt heart disease, young adults with DM1 may have underlying cardiac dysfunction detectable through advanced imaging techniques like STE [<xref rid="clc70153-bib-0009" ref-type="bibr">9</xref>].</p><p>Rakha et al. utilized 2D&#x02010;STE to assess LV function in pediatric patients with long&#x02010;standing T1DM. It was found that the mean LV&#x02010;GLS was significantly lower in diabetic patients compared to the control group, with values of &#x02212;19.7% versus &#x02212;21.8%, respectively, and a <italic toggle="yes">p</italic>&#x02010;value of 0.038. Additionally, the mean LV global circumferential strain (GCS) was also significantly reduced in the diabetic group, measuring &#x02212;21.3% compared to &#x02212;27.1% in controls, with a <italic toggle="yes">p</italic>&#x02010;value of 0.001. Some specific segments, such as the mid&#x02010;anterior, anterolateral, apical, and anterior segments, were more significantly affected in the diabetic group. Despite these findings, the EF derived from 2D speckle tracking did not show a statistically significant difference between the diabetic and control groups. The study highlighted that the mean HbA1c level was a significant predictor of decreased GLS in diabetic children. Overall, the results underscore the utility of 2D speckle tracking in detecting subclinical myocardial changes in pediatric patients with T1DM, even when conventional echocardiographic measures appear normal [<xref rid="clc70153-bib-0075" ref-type="bibr">75</xref>].</p><p>&#x00141;ukawska&#x02010;Tatarczuk et al. utilized 2D&#x02010;STE to assess LV function in women with T1DM, focusing on those with positive antithyroid peroxidase antibodies (aTPO+). The results revealed that the T1DM aTPO+ group exhibited significantly lower GLS values compared to both the T1DM aTPO&#x02013; group and healthy controls, indicating impaired myocardial function. Specifically, the lowest LS values were observed in the inferoseptal and anterolateral segments in the four&#x02010;chamber (4CH) view, with significant differences between the T1DM aTPO+ group and controls. Additionally, the two&#x02010;chamber (2CH) view showed significant differences in strain values between the T1DM aTPO+ and T1DM aTPO&#x02013; groups. The study also found that both T1DM groups had significantly lower anterolateral wall strain compared to controls, while only the T1DM aTPO+ group showed significantly lower anterior wall strain. These findings suggest that thyroid autoimmunity may contribute to early myocardial dysfunction in T1DM, particularly affecting specific LV segments. The study highlights the potential of STE as a sensitive tool for detecting subclinical cardiac dysfunction in this population [<xref rid="clc70153-bib-0013" ref-type="bibr">13</xref>].</p><p>Table&#x000a0;<xref rid="clc70153-tbl-0002" ref-type="table">2</xref> summarizes various studies that used 2D&#x02010;STE to assess cardiac function in patients with T1DM, providing details on the total number of participants, the number of T1DM patients, control groups, and key results for each study.</p><table-wrap position="float" id="clc70153-tbl-0002" content-type="Table"><label>Table 2</label><caption><p>Summary of studies using 2D&#x02010;STE to assess cardiac function in patients with T1DM.</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><thead valign="bottom"><tr valign="bottom" style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Study</th><th align="center" valign="bottom" rowspan="1" colspan="1">Total participants</th><th align="center" valign="bottom" rowspan="1" colspan="1">T1DM patients</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control group</th><th align="center" valign="bottom" rowspan="1" colspan="1">Key results</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Ahmed et al.</td><td align="center" valign="top" rowspan="1" colspan="1">54</td><td align="center" valign="top" rowspan="1" colspan="1">39 (13 M, 26 F)</td><td align="center" valign="top" rowspan="1" colspan="1">15 (5 M, 10 F)</td><td align="center" valign="top" rowspan="1" colspan="1">T1DM patients showed significantly lower LV and RV GLS compared to controls. LV GLS correlated negatively with HbA1c levels and diabetes duration.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Berceanu et al.</td><td align="center" valign="top" rowspan="1" colspan="1">130</td><td align="center" valign="top" rowspan="1" colspan="1">50 (26 M, 24 F)</td><td align="center" valign="top" rowspan="1" colspan="1">80 (55 M, 25 F)</td><td align="center" valign="top" rowspan="1" colspan="1">T1DM patients exhibited lower LV GLS and higher E/e' ratio compared to controls. RV free wall strain was also reduced in T1DM patients.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rakha et al.</td><td align="center" valign="top" rowspan="1" colspan="1">83</td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="center" valign="top" rowspan="1" colspan="1">35</td><td align="center" valign="top" rowspan="1" colspan="1">T1DM patients had significantly lower LV and RV GLS compared to controls. LV GLS correlated negatively with HbA1c levels and diabetes duration.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x00141;ukawska&#x02010;Tatarczuk et al.</td><td align="center" valign="top" rowspan="1" colspan="1">88</td><td align="center" valign="top" rowspan="1" colspan="1">59 (all F)</td><td align="center" valign="top" rowspan="1" colspan="1">29 (all F)</td><td align="center" valign="top" rowspan="1" colspan="1">T1DM patients with positive aTPO showed lower LV GLS compared to T1DM patients with negative aTPO and controls. RV function was also impaired in T1DM patients.</td></tr></tbody></table><table-wrap-foot><fn id="clc70153-tbl2-note-0001"><p>Abbreviations: aTPO&#x02009;=&#x02009;antithyroid peroxidase antibody, F&#x02009;=&#x02009;female, GLS&#x02009;=&#x02009;global longitudinal strain, HbA1c&#x02009;=&#x02009;glycated hemoglobin, LV&#x02009;=&#x02009;left ventricular, M&#x02009;=&#x02009;male, RV&#x02009;=&#x02009;right ventricular.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="clc70153-sec-0110"><label>6</label><title>Using the 2D&#x02010;STE to Assess Right and Left Ventricular Function in Patients With Gestational Diabetes Mellitus (GDM)</title><p>GDM is defined as glucose intolerance first recognized during pregnancy. Recent global estimates indicate a prevalence of approximately 14%&#x02013;16%, and this rate is expected to continue rising in the coming years [<xref rid="clc70153-bib-0076" ref-type="bibr">76</xref>, <xref rid="clc70153-bib-0077" ref-type="bibr">77</xref>]. 2D&#x02010;STE is a sensitive imaging technique used to detect subclinical cardiac dysfunction in patients with GDM [<xref rid="clc70153-bib-0078" ref-type="bibr">78</xref>, <xref rid="clc70153-bib-0079" ref-type="bibr">79</xref>]. Li et al. demonstrated that LV function in women with GDM was assessed using both conventional echocardiography and 2D&#x02010;STE. The results indicated that while conventional echocardiographic parameters and EF were similar between GDM patients and healthy controls, the LV&#x02010;GLS was significantly reduced in the GDM group. Notably, 66% of GDM patients had an absolute LV&#x02010;GLS of less than 20%, suggesting subclinical systolic dysfunction despite preserved EF. Furthermore, GDM patients showed significantly lower LA reservoir and conduit strain values, indicating early diastolic function impairment, although LA contractile function did not differ between the groups. Multivariate regression analysis confirmed that both LV&#x02010;GLS and LA conduit strain were independently associated with GDM. These findings suggest that 2D&#x02010;STE is more sensitive than conventional echocardiography in detecting early, subclinical myocardial dysfunction in pregnant women with GDM [<xref rid="clc70153-bib-0078" ref-type="bibr">78</xref>]. In another study, Sonaglioni et al. demonstrated that women with GDM experience significant subclinical impairment in both ventricular and atrial myocardial function, as assessed by 2D&#x02010;STE, compared to women with uncomplicated pregnancies. Specifically, women with GDM exhibited higher rates of overweight and obesity, increased LV mass, elevated filling pressures, and higher blood pressure, while maintaining a preserved EF. This indicates that conventional measures may overlook early dysfunction. The study revealed that myocardial strain indices&#x02014;including left and right ventricular global LS and both atrial reservoir strains&#x02014;were significantly lower in women with GDM, with these impairments persisting in about one&#x02010;third of cases postpartum. Moreover, it found that a higher BMI during pregnancy was the strongest independent predictor of persistent LV strain impairment after delivery, with a BMI of &#x02265;&#x02009;30&#x02009;kg/m&#x000b2; showing nearly perfect sensitivity and specificity for identifying at&#x02010;risk women. These findings suggest that even mild hyperglycemia in GDM, particularly in conjunction with obesity, can lead to early and persistent subclinical cardiac dysfunction [<xref rid="clc70153-bib-0079" ref-type="bibr">79</xref>]. The results underscore the importance of advanced echocardiographic techniques for early detection and the potential need for targeted postpartum cardiovascular risk management in this population.</p></sec><sec id="clc70153-sec-0120"><label>7</label><title>Future Directions</title><p>The comprehensive review of 2D&#x02010;STE in assessing cardiac function in diabetic patients has revealed several promising avenues for future research.</p><sec id="clc70153-sec-0130"><label>7.1</label><title>Longitudinal Studies</title><p>Long&#x02010;term follow&#x02010;up studies are needed to evaluate the prognostic value of 2D&#x02010;STE parameters in predicting cardiovascular outcomes in both T1DM and T2DM patients.</p></sec><sec id="clc70153-sec-0140"><label>7.2</label><title>Standardization</title><p>Efforts should be made to establish standardized protocols and reference values for 2D&#x02010;STE measurements specific to diabetic populations, accounting for age, gender, and diabetes duration.</p></sec><sec id="clc70153-sec-0150"><label>7.3</label><title>Integration With Other Modalities</title><p>Future research should explore the combination of 2D&#x02010;STE with other imaging modalities, such as cardiac MRI or CT, to provide a more comprehensive assessment of cardiac structure and function in diabetic patients.</p></sec><sec id="clc70153-sec-0160"><label>7.4</label><title>Therapeutic Interventions</title><p>Studies investigating the impact of various therapeutic interventions (e.g., novel antidiabetic medications, lifestyle modifications) on 2D&#x02010;STE parameters could help guide personalized treatment strategies.</p></sec><sec id="clc70153-sec-0170"><label>7.5</label><title>Machine Learning Applications</title><p>Developing machine learning algorithms to analyze 2D&#x02010;STE data could enhance the technique's diagnostic and prognostic capabilities in diabetic cardiomyopathy.</p></sec><sec id="clc70153-sec-0180"><label>7.6</label><title>Three&#x02010;Dimensional STE</title><p>Further exploration of three&#x02010;dimensional STE could provide additional insights into cardiac mechanics in diabetic patients, potentially offering even greater sensitivity in detecting subclinical dysfunction.</p></sec></sec><sec id="clc70153-sec-0190"><label>8</label><title>Limitations</title><p>Despite the promising results, several limitations should be considered.</p><sec id="clc70153-sec-0200"><label>8.1</label><title>Image Quality Dependence</title><p>The accuracy of 2D&#x02010;STE measurements is highly dependent on image quality, which can be challenging in certain patient populations (e.g., obese individuals).</p></sec><sec id="clc70153-sec-0210"><label>8.2</label><title>Lack of Standardization</title><p>The absence of universally accepted reference values and standardized protocols across different ultrasound systems and software platforms limits the comparability of results between studies.</p></sec><sec id="clc70153-sec-0220"><label>8.3</label><title>Technical Expertise</title><p>2D&#x02010;STE requires specialized training and expertise, which may limit its widespread adoption in clinical practice.</p></sec><sec id="clc70153-sec-0230"><label>8.4</label><title>Cost and Availability</title><p>The technology and software required for 2D&#x02010;STE may not be readily available in all healthcare settings, particularly in resource&#x02010;limited areas.</p></sec><sec id="clc70153-sec-0240"><label>8.5</label><title>Limited Long&#x02010;Term Data</title><p>There is a scarcity of long&#x02010;term follow&#x02010;up studies evaluating the prognostic value of 2D&#x02010;STE parameters in diabetic populations1.</p></sec><sec id="clc70153-sec-0250"><label>8.6</label><title>Confounding Factors</title><p>The impact of comorbidities common in diabetic patients (e.g., HT, obesity) on 2D&#x02010;STE parameters needs further clarification.</p></sec><sec id="clc70153-sec-0260"><label>8.7</label><title>Reproducibility Concerns</title><p>While 2D&#x02010;STE has shown good reproducibility in many studies, inter&#x02010;vendor variability and the potential for measurement errors in less experienced hands remain concerns.</p><p>Addressing these limitations and pursuing the outlined future directions will help solidify the role of 2D&#x02010;STE in the comprehensive cardiovascular evaluation and management of patients with DM.</p></sec></sec><sec sec-type="conclusions" id="clc70153-sec-0270"><label>9</label><title>Conclusion</title><p>2D&#x02010;STE has emerged as a powerful and sensitive tool for assessing cardiac function in patients with both T2DM and T1DM. This review highlights the significant contributions of 2D&#x02010;STE in detecting subclinical cardiac dysfunction, evaluating both left and right ventricular performance, and assessing the impact of various factors on myocardial function in diabetic patients. The ability of 2D&#x02010;STE to detect subtle changes in myocardial mechanics, even when conventional echocardiographic parameters appear normal, underscores its value in early diagnosis and risk stratification for both T2DM and T1DM patients. Key findings from the reviewed studies demonstrate the utility of 2D&#x02010;STE in assessing the relationship between glycemic control and cardiac function, evaluating the impact of EAT on myocardial performance, and detecting early changes in left atrial function across both types of diabetes. The technique has also shown promise in unmasking subclinical myocardial dysfunction during stress conditions and in identifying cardiac abnormalities associated with fQRS complexes in diabetic patients. Furthermore, 2D&#x02010;STE has demonstrated potential in evaluating left atrial dysfunction in diabetic patients with HF with preserved EF, providing additional prognostic information for both T1DM and T2DM populations. As research in this field continues to evolve, 2D&#x02010;STE is likely to play an increasingly important role in the comprehensive cardiovascular evaluation and management of individuals with both types of DM, potentially guiding personalized treatment strategies and improving long&#x02010;term outcomes.</p></sec><sec id="clc70153-sec-0290"><title>Ethics Statement</title><p>The authors have nothing to report.</p></sec><sec id="clc70153-sec-0300"><title>Consent</title><p>The authors have nothing to report.</p></sec><sec sec-type="COI-statement" id="clc70153-sec-0310"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec></body><back><ack id="clc70153-sec-0280"><title>Acknowledgments</title><p>Figure created using Biorender (<ext-link xlink:href="https://biorender.com/" ext-link-type="uri">https://biorender.com/</ext-link>).</p></ack><sec sec-type="data-availability" id="clc70153-sec-0330"><title>Data Availability Statement</title><p>The data used to support the findings of this study are available from the corresponding author upon request.</p></sec><ref-list content-type="cited-references" id="clc70153-bibl-0001"><title>References</title><ref id="clc70153-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="clc70153-cit-0001">
<string-name>
<given-names>X.&#x02010;T.</given-names>
<surname>Song</surname>
</string-name>, <string-name>
<given-names>S. K.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>P. Y.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Fan</surname>
</string-name>, and <string-name>
<given-names>Y. F.</given-names>
<surname>Rui</surname>
</string-name>, &#x0201c;<article-title>Association Between Epicardial Adipose Tissue and Left Ventricular Function in Type 2 Diabetes Mellitus: Assessment Using Two&#x02010;Dimensional Speckle Tracking Echocardiography</article-title>,&#x0201d; <source>Journal of Diabetes and its Complications</source>
<volume>36</volume>, no. <issue>5</issue> (<year>2022</year>): <elocation-id>108167</elocation-id>.<pub-id pub-id-type="pmid">35272930</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="clc70153-cit-0002">
<string-name>
<given-names>Y.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Lin</surname>
</string-name>, et al., &#x0201c;<article-title>Association of Glycemic Control With Right Ventricular Function Assessed by Two&#x02010;Dimensional Speckle&#x02010;Tracking and Three&#x02010;Dimensional Echocardiography in Type 2 Diabetes Mellitus</article-title>,&#x0201d; <source>Journal of the American Society of Echocardiography</source>
<volume>37</volume> (<year>2024</year>): <fpage>1156</fpage>&#x02013;<lpage>1166</lpage>.<pub-id pub-id-type="pmid">39278576</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="clc70153-cit-0003">
<string-name>
<given-names>M.</given-names>
<surname>Zakir</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Ahuja</surname>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>Surksha</surname>
</string-name>, et al., &#x0201c;<article-title>Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways</article-title>,&#x0201d; <source>Cureus</source>
<volume>15</volume>, no. <issue>9</issue> (<year>2023</year>): <elocation-id>e45835</elocation-id>.<pub-id pub-id-type="pmid">37881393</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="clc70153-cit-0004">
<string-name>
<given-names>N.</given-names>
<surname>Ghosh</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Chacko</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Bhattacharya</surname>
</string-name>, et al., &#x0201c;<article-title>Exploring the Complex Relationship Between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies</article-title>,&#x0201d; <source>Biomedicines</source>
<volume>11</volume>, no. <issue>4</issue> (<year>2023</year>): <fpage>1126</fpage>.<pub-id pub-id-type="pmid">37189744</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="clc70153-cit-0005">
<string-name>
<given-names>F. R.</given-names>
<surname>Prandi</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Evangelista</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Sergi</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Palazzuoli</surname>
</string-name>, and <string-name>
<given-names>F.</given-names>
<surname>Romeo</surname>
</string-name>, &#x0201c;<article-title>Mechanisms of Cardiac Dysfunction in Diabetic Cardiomyopathy: Molecular Abnormalities and Phenotypical Variants</article-title>,&#x0201d; <source>Heart Failure Reviews</source>
<volume>28</volume>, no. <issue>3</issue> (<year>2023</year>): <fpage>597</fpage>&#x02013;<lpage>606</lpage>.<pub-id pub-id-type="pmid">35001338</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="clc70153-cit-0006">
<string-name>
<given-names>Y.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Zhang</surname>
</string-name>, et al., &#x0201c;<article-title>Association of Peripheral Neuropathy With Subclinical Left Ventricular Dysfunction in Patients With Type 2 Diabetes</article-title>,&#x0201d; <source>Journal of Diabetes and its Complications</source>
<volume>37</volume>, no. <issue>2</issue> (<year>2023</year>): <elocation-id>108406</elocation-id>.<pub-id pub-id-type="pmid">36682230</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="clc70153-cit-0007">
<string-name>
<given-names>M. T.</given-names>
<surname>Jensen</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Sogaard</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Gustafsson</surname>
</string-name>, et al., &#x0201c;<article-title>Echocardiography Improves Prediction of Major Adverse Cardiovascular Events in a Population With Type 1 Diabetes and Without Known Heart Disease: The Thousand &#x00026; 1 Study</article-title>,&#x0201d; <source>Diabetologia</source>
<volume>62</volume> (<year>2019</year>): <fpage>2354</fpage>&#x02013;<lpage>2364</lpage>.<pub-id pub-id-type="pmid">31664481</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="clc70153-cit-0008">
<string-name>
<given-names>S.&#x02010;M.</given-names>
<surname>Ghoreyshi&#x02010;Hefzabad</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Jeyaprakash</surname>
</string-name>, <string-name>
<given-names>H. Q.</given-names>
<surname>Vo</surname>
</string-name>, et al., &#x0201c;<article-title>Subclinical Systolic Dysfunction Detected by 2D Speckle Tracking Echocardiography in Adults With Diabetes Mellitus: Systematic Review and Meta&#x02010;Analysis of 6668 Individuals With Diabetes Mellitus and 7218 Controls</article-title>,&#x0201d; <source>International Journal of Cardiovascular Imaging</source>
<volume>39</volume>, no. <issue>5</issue> (<year>2023</year>): <fpage>977</fpage>&#x02013;<lpage>989</lpage>.<pub-id pub-id-type="pmid">36995526</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="clc70153-cit-0009">
<string-name>
<given-names>M.</given-names>
<surname>Berceanu</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Mirea</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Donoiu</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Militaru</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>S&#x00103;ftoiu</surname>
</string-name>, and <string-name>
<given-names>O.</given-names>
<surname>Istr&#x00103;toaie</surname>
</string-name>, &#x0201c;<article-title>Myocardial Function Assessed by Multi&#x02010;Layered Two&#x02010;Dimensional Speckle Tracking Analysis in Asymptomatic Young Subjects With Diabetes Mellitus Type 1</article-title>,&#x0201d; <source>Cardiology</source>
<volume>145</volume>, no. <issue>2</issue> (<year>2020</year>): <fpage>80</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="pmid">31825945</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="clc70153-cit-0010">
<string-name>
<given-names>T.</given-names>
<surname>Wu</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Zhang</surname>
</string-name>, and <string-name>
<given-names>L. G.</given-names>
<surname>Gong</surname>
</string-name>, &#x0201c;<article-title>Early Impairment of Right Ventricular Systolic Function in Patients With Prediabetes and Type 2 Diabetes Mellitus: An Analysis of Two&#x02010;Dimensional Speckle Tracking Echocardiography</article-title>,&#x0201d; <source>Echocardiography</source>
<volume>40</volume>, no. <issue>8</issue> (<year>2023</year>): <fpage>831</fpage>&#x02013;<lpage>840</lpage>.<pub-id pub-id-type="pmid">37449864</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="clc70153-cit-0011">
<string-name>
<given-names>X.</given-names>
<surname>Song</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Fan</surname>
</string-name>, and <string-name>
<given-names>Y.</given-names>
<surname>Rui</surname>
</string-name>, &#x0201c;<article-title>Epicardial Adipose Tissue and Right Ventricular Function in Type 2 Diabetes Mellitus Using Two&#x02010;Dimensional Speckle Tracking Echocardiography</article-title>,&#x0201d; <source>Diabetes and Vascular Disease Research</source>
<volume>19</volume>, no. <issue>4</issue> (<year>2022</year>): <elocation-id>14791641221118622</elocation-id>.<pub-id pub-id-type="pmid">35999047</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="clc70153-cit-0012">
<string-name>
<given-names>W.</given-names>
<surname>Chang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Sun</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Yu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Li</surname>
</string-name>, and <string-name>
<given-names>G.</given-names>
<surname>Li</surname>
</string-name>, &#x0201c;<article-title>Evaluation of Left Atrial Function in Type 2 Diabetes Mellitus Patients With Nonalcoholic Fatty Liver Disease by Two&#x02010;Dimensional Speckle Tracking Echocardiography</article-title>,&#x0201d; <source>Echocardiography</source>
<volume>36</volume>, no. <issue>7</issue> (<year>2019</year>): <fpage>1290</fpage>&#x02013;<lpage>1297</lpage>.<pub-id pub-id-type="pmid">31206765</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="clc70153-cit-0013">
<string-name>
<given-names>M. M.</given-names>
<surname>&#x00141;ukawska&#x02010;Tatarczuk</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Pawlak</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Zieli&#x00144;ski</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Franek</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Czupryniak</surname>
</string-name>, and <string-name>
<given-names>B.</given-names>
<surname>Mrozikiewicz&#x02010;Rakowska</surname>
</string-name>, &#x0201c;<article-title>Association of Antithyroid Peroxidase Antibodies With Cardiac Function in Euthyroid Women With Type 1 Diabetes Mellitus&#x02014;Assessment With Two&#x02010;Dimensional Speckle&#x02011;Tracking Echocardiography</article-title>,&#x0201d; <source>Endokrynologia Polska</source>
<volume>73</volume>, no. <issue>5</issue> (<year>2022</year>): <fpage>812</fpage>&#x02013;<lpage>822</lpage>.<pub-id pub-id-type="pmid">35971937</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="clc70153-cit-0014">
<string-name>
<given-names>L.</given-names>
<surname>Hamabe</surname>
</string-name>, <string-name>
<given-names>A. S.</given-names>
<surname>Mandour</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Shimada</surname>
</string-name>, et al., &#x0201c;<article-title>Role of Two&#x02010;Dimensional Speckle&#x02010;Tracking Echocardiography in Early Detection of Left Ventricular Dysfunction in Dogs</article-title>,&#x0201d; <source>Animals: An Open Access Journal from MDPI</source>
<volume>11</volume>, no. <issue>8</issue> (<year>2021</year>): <fpage>2361</fpage>.<pub-id pub-id-type="pmid">34438818</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="clc70153-cit-0015">
<string-name>
<given-names>L.</given-names>
<surname>Longobardo</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Suma</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Jain</surname>
</string-name>, et al., &#x0201c;<article-title>Role of Two&#x02010;Dimensional Speckle&#x02010;Tracking Echocardiography Strain in the Assessment of Right Ventricular Systolic Function and Comparison With Conventional Parameters</article-title>,&#x0201d; <source>Journal of the American Society of Echocardiography</source>
<volume>30</volume>, no. <issue>10</issue> (<year>2017</year>): <fpage>937</fpage>&#x02013;<lpage>946. e6</lpage>.<pub-id pub-id-type="pmid">28803684</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="clc70153-cit-0016">
<string-name>
<given-names>A. A. G.</given-names>
<surname>Tantawy</surname>
</string-name>, <string-name>
<given-names>N. H. K.</given-names>
<surname>Elsherif</surname>
</string-name>, <string-name>
<given-names>N. M.</given-names>
<surname>Habeeb</surname>
</string-name>, <string-name>
<given-names>E. M.</given-names>
<surname>Hasan</surname>
</string-name>, and <string-name>
<given-names>A. E.</given-names>
<surname>Abdelhameed</surname>
</string-name>, &#x0201c;<article-title>A Two&#x02010;Dimensional Speckle&#x02010;Tracking Echocardiography for the Diagnosis of Early Myocardial Disease in Beta&#x02010;Thalassemia Major Patients</article-title>,&#x0201d; <source>Annals of Pediatric Cardiology</source>
<volume>15</volume>, no. <issue>3</issue> (<year>2022</year>): <fpage>257</fpage>&#x02013;<lpage>265</lpage>.<pub-id pub-id-type="pmid">36589651</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="clc70153-cit-0017">
<string-name>
<given-names>T.</given-names>
<surname>Haque</surname>
</string-name>, &#x0201c;<article-title>Myocardial Strain Imaging Using Two and Three&#x02010;Dimensional Speckle Tracking Echocardiography: Clinical Applications</article-title>,&#x0201d; <source>Cardiovascular Journal</source>
<volume>11</volume>, no. <issue>2</issue> (<year>2019</year>): <fpage>167</fpage>&#x02013;<lpage>182</lpage>.</mixed-citation></ref><ref id="clc70153-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="clc70153-cit-0018">
<string-name>
<given-names>L.</given-names>
<surname>Martini</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Lisi</surname>
</string-name>, <string-name>
<given-names>M. C.</given-names>
<surname>Pastore</surname>
</string-name>, et al., &#x0201c;<article-title>The Role of Speckle Tracking Echocardiography in the Evaluation of Advanced&#x02010;Heart&#x02010;Failure Patients</article-title>,&#x0201d; <source>Journal of Clinical Medicine</source>
<volume>13</volume>, no. <issue>14</issue> (<year>2024</year>): <fpage>4037</fpage>.<pub-id pub-id-type="pmid">39064077</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="clc70153-cit-0019">
<string-name>
<given-names>M. G. M. A.&#x02010;E.</given-names>
<surname>Alsayed</surname>
</string-name>, &#x0201c;<article-title>Clinical Applications of Left Ventricular Global Longitudinal Strain by 2D&#x02010;Speckle Tracking Echocardiography</article-title>,&#x0201d; <source>Tobacco Regulatory Science (TRS)</source>
<volume>9</volume> (<year>2023</year>): <fpage>4825</fpage>&#x02013;<lpage>4839</lpage>.</mixed-citation></ref><ref id="clc70153-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="clc70153-cit-0020">
<string-name>
<given-names>Y.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Haines</surname>
</string-name>, et al., &#x0201c;<article-title>Prognostic Value of Right Ventricular Two&#x02010;Dimensional and Three&#x02010;Dimensional Speckle&#x02010;Tracking Strain in Pulmonary Arterial Hypertension: Superiority of Longitudinal Strain Over Circumferential and Radial Strain</article-title>,&#x0201d; <source>Journal of the American Society of Echocardiography</source>
<volume>33</volume>, no. <issue>8</issue> (<year>2020</year>): <fpage>985</fpage>&#x02013;<lpage>994. e1</lpage>.<pub-id pub-id-type="pmid">32532643</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="clc70153-cit-0021">
<string-name>
<given-names>M.</given-names>
<surname>Hadadi</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Mohseni&#x02010;Badalabadi</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Hosseinsabet</surname>
</string-name>, &#x0201c;<article-title>Effects of Obesity on Left Atrial Phasic Functions in Patients With Chronic Ischemic Heart Disease and Preserved Left Ventricular Ejection Fraction Without Recent Myocardial Infarction: A Two&#x02010;Dimensional Speckle&#x02010;Tracking Echocardiography Study</article-title>,&#x0201d; <source>Journal of Ultrasound</source>
<volume>25</volume>, no. <issue>3</issue> (<year>2022</year>): <fpage>521</fpage>&#x02013;<lpage>527</lpage>.<pub-id pub-id-type="pmid">34855185</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="clc70153-cit-0022">
<string-name>
<given-names>R.</given-names>
<surname>Blessing</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Drosos</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Molitor</surname>
</string-name>, et al., &#x0201c;<article-title>Evaluation of Right&#x02010;Ventricular Function by Two&#x02010;Dimensional Echocardiography and Two&#x02010;Dimensional Speckle&#x02010;Tracking Echocardiography in Patients With Successful RCA CTO Recanalization</article-title>,&#x0201d; <source>Clinical Research in Cardiology</source>
<volume>112</volume>, no. <issue>10</issue> (<year>2023</year>): <fpage>1454</fpage>&#x02013;<lpage>1462</lpage>.<pub-id pub-id-type="pmid">37526696</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="clc70153-cit-0023">
<string-name>
<given-names>R.</given-names>
<surname>Iacobelli</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Di Molfetta</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Cobianchi Bellisari</surname>
</string-name>, et al., &#x0201c;<article-title>Changes in Left and Right Ventricular Two&#x02010;Dimensional Echocardiographic Speckle&#x02010;Tracking Indices in Pediatric LVAD Population: A Retrospective Clinical Study</article-title>,&#x0201d; <source>International Journal of Artificial Organs</source>
<volume>42</volume>, no. <issue>12</issue> (<year>2019</year>): <fpage>711</fpage>&#x02013;<lpage>716</lpage>.<pub-id pub-id-type="pmid">31238772</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="clc70153-cit-0024">
<string-name>
<given-names>H.</given-names>
<surname>Kamel</surname>
</string-name>, <string-name>
<given-names>A. T.</given-names>
<surname>Elsayegh</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Nazmi</surname>
</string-name>, and <string-name>
<given-names>H. M.</given-names>
<surname>Attia</surname>
</string-name>, &#x0201c;<article-title>Assessment of Left Ventricular Systolic Function Using Two&#x02010;and Three&#x02010;Dimensional Speckle Tracking Echocardiography Among Healthy Preschool&#x02010;Age Pediatric Children</article-title>,&#x0201d; <source>Egyptian Heart Journal</source>
<volume>74</volume>, no. <issue>1</issue> (<year>2022</year>): <fpage>21</fpage>.</mixed-citation></ref><ref id="clc70153-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="clc70153-cit-0025">
<string-name>
<given-names>B.</given-names>
<surname>Yaman</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Akp&#x00131;nar</surname>
</string-name>, <string-name>
<given-names>H. S.</given-names>
<surname>Kemal</surname>
</string-name>, et al., &#x0201c;<article-title>The Beneficial Effect of Low&#x02010;Intensity Exercise on Cardiac Performance Assessed by Two&#x02010;Dimensional Speckle Tracking Echocardiography</article-title>,&#x0201d; <source>Echocardiography</source>
<volume>37</volume>, no. <issue>12</issue> (<year>2020</year>): <fpage>1989</fpage>&#x02013;<lpage>1999</lpage>.<pub-id pub-id-type="pmid">33070385</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="clc70153-cit-0026">
<string-name>
<given-names>H.</given-names>
<surname>Blessberger</surname>
</string-name> and <string-name>
<given-names>T.</given-names>
<surname>Binder</surname>
</string-name>, &#x0201c;<article-title>Two Dimensional Speckle Tracking Echocardiography: Basic Principles</article-title>,&#x0201d; <source>Heart</source>
<volume>96</volume>, no. <issue>9</issue> (<year>2010</year>): <fpage>716</fpage>&#x02013;<lpage>722</lpage>.<pub-id pub-id-type="pmid">20424157</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0027"><label>27</label><mixed-citation publication-type="book" id="clc70153-cit-0027">
<string-name>
<given-names>A.</given-names>
<surname>Popielarz&#x02010;Grygalewicz</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Stelmachowska&#x02010;Bana&#x0015b;</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>G&#x00119;sior</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Czubalska</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Zgliczy&#x00144;ski</surname>
</string-name>, and <string-name>
<given-names>W.</given-names>
<surname>Kochman</surname>
</string-name>, &#x0201c;<part-title>The Influence of Acromegaly Treatment on Subclinical Left Ventricular Dysfunction Assessed by Two&#x02010;Dimensional Speckle Tracking Echocardiography (2D&#x02010;STE)&#x02010;Preliminary Results</part-title>,&#x0201d; in <source>Endocrine Abstracts</source> (<publisher-name>Bioscientifica</publisher-name>, <year>2019</year>).</mixed-citation></ref><ref id="clc70153-bib-0028"><label>28</label><mixed-citation publication-type="book" id="clc70153-cit-0028">
<string-name>
<given-names>A.</given-names>
<surname>Popielarz&#x02010;Grygalewicz</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Stelmachowska&#x02010;Bana&#x0015b;</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>G&#x00119;sior</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Czubalska</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Zgliczy&#x00144;ski</surname>
</string-name>, and <string-name>
<given-names>W.</given-names>
<surname>Kochman</surname>
</string-name>, &#x0201c;<part-title>Subclinical Left Ventricular Dysfunction in Patients With Naive Acromegaly Assessed by Two&#x02010;Dimensional Speckle Tracking Echocardiography (2D&#x02010;STE)</part-title>,&#x0201d; in <source>Endocrine Abstracts</source> (<publisher-name>Bioscientifica</publisher-name>, <year>2018</year>).</mixed-citation></ref><ref id="clc70153-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="clc70153-cit-0029">
<string-name>
<given-names>M. C.</given-names>
<surname>Arciniegas Calle</surname>
</string-name>, <string-name>
<given-names>N. P.</given-names>
<surname>Sandhu</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Xia</surname>
</string-name>, et al., &#x0201c;<article-title>Two&#x02010;Dimensional Speckle Tracking Echocardiography Predicts Early Subclinical Cardiotoxicity Associated With Anthracycline&#x02010;Trastuzumab Chemotherapy in Patients With Breast Cancer</article-title>,&#x0201d; <source>BMC Cancer</source>
<volume>18</volume> (<year>2018</year>): <fpage>1037</fpage>.<pub-id pub-id-type="pmid">30359235</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="clc70153-cit-0030">
<string-name>
<given-names>W.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Li</surname>
</string-name>, et al., &#x0201c;<article-title>Two&#x02010;Dimensional Speckle Tracking Echocardiography Help Identify Breast Cancer Therapeutics&#x02013;Related Cardiac Dysfunction</article-title>,&#x0201d; <source>BMC Cardiovascular Disorders</source>
<volume>22</volume>, no. <issue>1</issue> (<year>2022</year>): <fpage>548</fpage>.<pub-id pub-id-type="pmid">36522712</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="clc70153-cit-0031">
<string-name>
<given-names>R. M.</given-names>
<surname>Abdulrahman</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Delgado</surname>
</string-name>, <string-name>
<given-names>A. C. T.</given-names>
<surname>Ng</surname>
</string-name>, et al., &#x0201c;<article-title>Abnormal Cardiac Contractility in Long&#x02010;Term Exogenous Subclinical Hyperthyroid Patients as Demonstrated by Two&#x02010;Dimensional Echocardiography Speckle Tracking Imaging</article-title>,&#x0201d; <source>European Journal of Endocrinology</source>
<volume>163</volume>, no. <issue>3</issue> (<year>2010</year>): <fpage>435</fpage>&#x02013;<lpage>441</lpage>.<pub-id pub-id-type="pmid">20587582</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="clc70153-cit-0032">
<string-name>
<given-names>X.</given-names>
<surname>Tao</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Jiang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Liu</surname>
</string-name>, et al., &#x0201c;<article-title>Predicting Three&#x02010;Month Fasting Blood Glucose and Glycated Hemoglobin Changes in Patients With Type 2 Diabetes Mellitus Based on Multiple Machine Learning Algorithms</article-title>,&#x0201d; <source>Scientific Reports</source>
<volume>13</volume>, no. <issue>1</issue> (<year>2023</year>): <elocation-id>16437</elocation-id>.<pub-id pub-id-type="pmid">37777593</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="clc70153-cit-0033">
<string-name>
<given-names>M.</given-names>
<surname>Tadic</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Nita</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Schneider</surname>
</string-name>, et al., &#x0201c;<article-title>The Predictive Value of Right Ventricular Longitudinal Strain in Pulmonary Hypertension, Heart Failure, and Valvular Diseases</article-title>,&#x0201d; <source>Frontiers in Cardiovascular Medicine</source>
<volume>8</volume> (<year>2021</year>): <elocation-id>698158</elocation-id>.<pub-id pub-id-type="pmid">34222387</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="clc70153-cit-0034">
<string-name>
<given-names>H.</given-names>
<surname>Motoki</surname>
</string-name>, <string-name>
<given-names>A. G.</given-names>
<surname>Borowski</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Shrestha</surname>
</string-name>, et al., &#x0201c;<article-title>Right Ventricular Global Longitudinal Strain Provides Prognostic Value Incremental to Left Ventricular Ejection Fraction in Patients With Heart Failure</article-title>,&#x0201d; <source>Journal of the American Society of Echocardiography</source>
<volume>27</volume>, no. <issue>7</issue> (<year>2014</year>): <fpage>726</fpage>&#x02013;<lpage>732</lpage>.<pub-id pub-id-type="pmid">24679740</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="clc70153-cit-0035">
<string-name>
<given-names>R.</given-names>
<surname>Wilson</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Eguchi</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Orihara</surname>
</string-name>, et al., &#x0201c;<article-title>Association Between Right Ventricular Global Longitudinal Strain and Mortality in Intermediate&#x02010;Risk Pulmonary Embolism</article-title>,&#x0201d; <source>Echocardiography</source>
<volume>41</volume>, no. <issue>4</issue> (<year>2024</year>): <elocation-id>e15815</elocation-id>.<pub-id pub-id-type="pmid">38634182</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="clc70153-cit-0036">
<string-name>
<given-names>H.</given-names>
<surname>Usuku</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Yamamoto</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Sueta</surname>
</string-name>, et al., &#x0201c;<article-title>Prognostic Value of Right Ventricular Global Longitudinal Strain in Patients With Immunoglobulin Light&#x02010;Chain Cardiac Amyloidosis</article-title>,&#x0201d; <source>European Heart Journal Open</source>
<volume>3</volume>, no. <issue>3</issue> (<year>2023</year>): <fpage>oead048</fpage>.<pub-id pub-id-type="pmid">37214543</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="clc70153-cit-0037">
<string-name>
<given-names>S. L.</given-names>
<surname>Purwowiyoto</surname>
</string-name> and <string-name>
<given-names>R.</given-names>
<surname>Halomoan</surname>
</string-name>, &#x0201c;<article-title>Highlighting the Role of Global Longitudinal Strain Assessment in Valvular Heart Disease</article-title>,&#x0201d; <source>Egyptian Heart Journal</source>
<volume>74</volume>, no. <issue>1</issue> (<year>2022</year>): <fpage>46</fpage>.</mixed-citation></ref><ref id="clc70153-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="clc70153-cit-0038">
<string-name>
<given-names>C.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>B. K.</given-names>
<surname>Adhikari</surname>
</string-name>, et al., &#x0201c;<article-title>The Role of Epicardial Adipose Tissue Dysfunction in Cardiovascular Diseases: An Overview of Pathophysiology, Evaluation, and Management</article-title>,&#x0201d; <source>Frontiers in Endocrinology</source>
<volume>14</volume> (<year>2023</year>): <elocation-id>1167952</elocation-id>.<pub-id pub-id-type="pmid">37260440</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="clc70153-cit-0039">
<string-name>
<given-names>G.</given-names>
<surname>Iacobellis</surname>
</string-name>, &#x0201c;<article-title>Epicardial Adipose Tissue in Contemporary Cardiology</article-title>,&#x0201d; <source>Nature Reviews Cardiology</source>
<volume>19</volume>, no. <issue>9</issue> (<year>2022</year>): <fpage>593</fpage>&#x02013;<lpage>606</lpage>.<pub-id pub-id-type="pmid">35296869</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="clc70153-cit-0040">
<string-name>
<given-names>A. H.</given-names>
<surname>Talman</surname>
</string-name>, <string-name>
<given-names>P. J.</given-names>
<surname>Psaltis</surname>
</string-name>, <string-name>
<given-names>J. D.</given-names>
<surname>Cameron</surname>
</string-name>, <string-name>
<given-names>I. T.</given-names>
<surname>Meredith</surname>
</string-name>, <string-name>
<given-names>S. K.</given-names>
<surname>Seneviratne</surname>
</string-name>, and <string-name>
<given-names>D. T.</given-names>
<surname>Wong</surname>
</string-name>, &#x0201c;<article-title>Epicardial Adipose Tissue: Far More Than a Fat Depot</article-title>,&#x0201d; <source>Cardiovascular Diagnosis and Therapy</source>
<volume>4</volume>, no. <issue>6</issue> (<year>2014</year>): <fpage>416</fpage>&#x02013;<lpage>429</lpage>.<pub-id pub-id-type="pmid">25610800</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="clc70153-cit-0041">
<string-name>
<given-names>A. M.</given-names>
<surname>Ansaldo</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Montecucco</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Sahebkar</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Dallegri</surname>
</string-name>, and <string-name>
<given-names>F.</given-names>
<surname>Carbone</surname>
</string-name>, &#x0201c;<article-title>Epicardial Adipose Tissue and Cardiovascular Diseases</article-title>,&#x0201d; <source>International Journal of Cardiology</source>
<volume>278</volume> (<year>2019</year>): <fpage>254</fpage>&#x02013;<lpage>260</lpage>.<pub-id pub-id-type="pmid">30297191</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="clc70153-cit-0042">
<string-name>
<given-names>Y.</given-names>
<surname>Song</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Tan</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Deng</surname>
</string-name>, et al., &#x0201c;<article-title>Epicardial Adipose Tissue, Metabolic Disorders, and Cardiovascular Diseases: Recent Advances Classified by Research Methodologies</article-title>,&#x0201d; <source>MedComm</source>
<volume>4</volume>, no. <issue>6</issue> (<year>2023</year>): <elocation-id>e413</elocation-id>.<pub-id pub-id-type="pmid">37881786</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="clc70153-cit-0043">
<string-name>
<given-names>J.</given-names>
<surname>Xu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Xue</surname>
</string-name>, <string-name>
<given-names>Q.</given-names>
<surname>Chen</surname>
</string-name>, et al., &#x0201c;<article-title>Identifying Distinct Risk Thresholds of Glycated Hemoglobin and Systolic Blood Pressure for Rapid Albuminuria Progression in Type 2 Diabetes From NHANES (1999&#x02013;2018)</article-title>,&#x0201d; <source>Frontiers in Medicine</source>
<volume>9</volume> (<year>2022</year>): <elocation-id>928825</elocation-id>.<pub-id pub-id-type="pmid">35795642</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="clc70153-cit-0044">
<string-name>
<given-names>X.</given-names>
<surname>Huang</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Qin</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Guo</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Cao</surname>
</string-name>, and <string-name>
<given-names>C.</given-names>
<surname>Tang</surname>
</string-name>, &#x0201c;<article-title>Association of Hemoglobin A1c With the Incidence of Hypertension: A Large Prospective Study</article-title>,&#x0201d; <source>Frontiers in Endocrinology</source>
<volume>13</volume> (<year>2023</year>): <elocation-id>1098012</elocation-id>.<pub-id pub-id-type="pmid">36726461</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="clc70153-cit-0045">
<string-name>
<given-names>T.</given-names>
<surname>Takao</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Matsuyama</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Suka</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Yanagisawa</surname>
</string-name>, and <string-name>
<given-names>Y.</given-names>
<surname>Iwamoto</surname>
</string-name>, &#x0201c;<article-title>The Combined Effect of Visit&#x02010;to&#x02010;Visit Variability in HbA1c and Systolic Blood Pressure on the Incidence of Cardiovascular Events in Patients With Type 2 Diabetes</article-title>,&#x0201d; <source>BMJ Open Diabetes Research &#x00026; Care</source>
<volume>3</volume>, no. <issue>1</issue> (<year>2015</year>): <elocation-id>e000129</elocation-id>.</mixed-citation></ref><ref id="clc70153-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="clc70153-cit-0046">
<string-name>
<given-names>M.</given-names>
<surname>Kosmalski</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Zi&#x000f3;&#x00142;kowska</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Czarny</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Szemraj</surname>
</string-name>, and <string-name>
<given-names>T.</given-names>
<surname>Pietras</surname>
</string-name>, &#x0201c;<article-title>The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus</article-title>,&#x0201d; <source>Journal of Clinical Medicine</source>
<volume>11</volume>, no. <issue>5</issue> (<year>2022</year>): <fpage>1375</fpage>.<pub-id pub-id-type="pmid">35268466</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="clc70153-cit-0047">
<string-name>
<given-names>C.&#x02010;T.</given-names>
<surname>Diaconu</surname>
</string-name> and <string-name>
<given-names>C.</given-names>
<surname>Guja</surname>
</string-name>, &#x0201c;<article-title>Nonalcoholic Fatty Liver Disease and Its Complex Relation With Type 2 Diabetes Mellitus&#x02014;From Prevalence to Diagnostic Approach and Treatment Strategies</article-title>,&#x0201d; <source>Journal of Clinical Medicine</source>
<volume>11</volume>, no. <issue>17</issue> (<year>2022</year>): <fpage>5144</fpage>.<pub-id pub-id-type="pmid">36079070</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="clc70153-cit-0048">
<string-name>
<given-names>J.</given-names>
<surname>Huang</surname>
</string-name>, <string-name>
<given-names>H. L.</given-names>
<surname>Hu</surname>
</string-name>, <string-name>
<given-names>Z. N.</given-names>
<surname>Yan</surname>
</string-name>, et al., &#x0201c;<article-title>Peak Systolic Longitudinal Rotation: A New Tool for Detecting Left Ventricular Systolic Function in Patients With Type 2 Diabetes Mellitus by Two&#x02010;Dimensional Speckle Tracking Echocardiography</article-title>,&#x0201d; <source>BMC Cardiovascular Disorders</source>
<volume>19</volume> (<year>2019</year>): <fpage>137</fpage>.<pub-id pub-id-type="pmid">31174469</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="clc70153-cit-0049">
<string-name>
<given-names>J.</given-names>
<surname>Zhu</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Xie</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Zhuo</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Huang</surname>
</string-name>, &#x0201c;<article-title>Impact of Glycemic Control on Biventricular Function in Patients With Type 2 Diabetes Mellitus: A Cardiac Magnetic Resonance Tissue Tracking Study</article-title>,&#x0201d; <source>Insights Into Imaging</source>
<volume>14</volume>, no. <issue>1</issue> (<year>2023</year>): <fpage>7</fpage>.<pub-id pub-id-type="pmid">36630007</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="clc70153-cit-0050">
<string-name>
<given-names>D.</given-names>
<surname>Carvalho</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Haaverstad</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Cumberledge</surname>
</string-name>, et al., &#x0201c;<article-title>Dobutamine Stress Echocardiography for Assessment of Myocardial Viability: Impact of Beta&#x02010;Blockade on Exam Accuracy</article-title>,&#x0201d; <source>Cardiology Letters</source>
<volume>87</volume>, no. <issue>4</issue> (<year>2024</year>): <fpage>329</fpage>&#x02013;<lpage>335</lpage>.</mixed-citation></ref><ref id="clc70153-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="clc70153-cit-0051">
<string-name>
<given-names>H.</given-names>
<surname>Ismail</surname>
</string-name>, <string-name>
<given-names>J. K.</given-names>
<surname>Gabriels</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Chang</surname>
</string-name>, et al., &#x0201c;<article-title>Site&#x02010;Specific Effects of Dobutamine on Cardiac Conduction and Refractoriness</article-title>,&#x0201d; <source>Journal of Interventional Cardiac Electrophysiology</source>
<volume>67</volume>, no. <issue>1</issue> (<year>2024</year>): <fpage>71</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">37227538</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="clc70153-cit-0052">
<string-name>
<given-names>M. G.</given-names>
<surname>Mousa</surname>
</string-name>, <string-name>
<given-names>I. M. R.</given-names>
<surname>Faheem</surname>
</string-name>, <string-name>
<given-names>A. F.</given-names>
<surname>Elkhateeb</surname>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>Saad</surname>
</string-name>, and <string-name>
<given-names>K. A. E.</given-names>
<surname>El&#x02010;Khashab</surname>
</string-name>, &#x0201c;<article-title>Dobutamine Stress Echocardiography in Patients With Chronic Peripheral Artery Disease</article-title>,&#x0201d; <source>International Journal of Health Sciences</source>
<volume>6</volume>, no. <issue>S7</issue> (<year>2023</year>): <fpage>6974</fpage>&#x02013;<lpage>6990</lpage>.</mixed-citation></ref><ref id="clc70153-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="clc70153-cit-0053">
<string-name>
<given-names>C.</given-names>
<surname>Philouze</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Obert</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Nottin</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Benamor</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Barthez</surname>
</string-name>, and <string-name>
<given-names>F.</given-names>
<surname>Aboukhoudir</surname>
</string-name>, &#x0201c;<article-title>Dobutamine Stress Echocardiography Unmasks Early Left Ventricular Dysfunction in Asymptomatic Patients With Uncomplicated Type 2 Diabetes: A Comprehensive Two&#x02010;Dimensional Speckle&#x02010;Tracking Imaging Study</article-title>,&#x0201d; <source>Journal of the American Society of Echocardiography</source>
<volume>31</volume>, no. <issue>5</issue> (<year>2018</year>): <fpage>587</fpage>&#x02013;<lpage>597</lpage>.<pub-id pub-id-type="pmid">29526563</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="clc70153-cit-0054">
<string-name>
<given-names>Y.</given-names>
<surname>Tian</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>Q.</given-names>
<surname>Yan</surname>
</string-name>, et al., &#x0201c;<article-title>Fragmented QRS Complex in Healthy Adults: Prevalence, Characteristics, Mechanisms, and Clinical Implications</article-title>,&#x0201d; <source>International Journal of Heart Rhythm</source>
<volume>2</volume>, no. <issue>1</issue> (<year>2017</year>): <fpage>34</fpage>&#x02013;<lpage>39</lpage>.</mixed-citation></ref><ref id="clc70153-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="clc70153-cit-0055">
<string-name>
<given-names>A. C.</given-names>
<surname>Ratheendran</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Subramanian</surname>
</string-name>, <string-name>
<given-names>D. K.</given-names>
<surname>Bhanu</surname>
</string-name>, et al., &#x0201c;<article-title>Fragmented QRS on Electrocardiography as a Predictor of Myocardial Scar in Patients With Hypertrophic Cardiomyopathy</article-title>,&#x0201d; <source>Acta Cardiologica</source>
<volume>75</volume> (<year>2020</year>): <fpage>42</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="pmid">30602338</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="clc70153-cit-0056">
<string-name>
<given-names>M. K.</given-names>
<surname>Das</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Khan</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Jacob</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Kumar</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Mahenthiran</surname>
</string-name>, &#x0201c;<article-title>Significance of a Fragmented QRS Complex Versus a Q Wave in Patients With Coronary Artery Disease</article-title>,&#x0201d; <source>Circulation</source>
<volume>113</volume>, no. <issue>21</issue> (<year>2006</year>): <fpage>2495</fpage>&#x02013;<lpage>2501</lpage>.<pub-id pub-id-type="pmid">16717150</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="clc70153-cit-0057">
<string-name>
<given-names>N.</given-names>
<surname>Engstrom</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Dobson</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Ng</surname>
</string-name>, and <string-name>
<given-names>H.</given-names>
<surname>Letson</surname>
</string-name>, &#x0201c;<article-title>Fragmented QRS Is Associated With Ventricular Arrhythmias in Heart Failure Patients: A Systematic Review and Meta&#x02010;Analysis</article-title>,&#x0201d; <source>Annals of Noninvasive Electrocardiology</source>
<volume>27</volume>, no. <issue>1</issue> (<year>2022</year>): <elocation-id>e12910</elocation-id>.<pub-id pub-id-type="pmid">34766402</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="clc70153-cit-0058">
<string-name>
<given-names>A.</given-names>
<surname>Bayramo&#x0011f;lu</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Ta&#x0015f;olar</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Kaya</surname>
</string-name>, et al., &#x0201c;<article-title>Fragmented QRS Complexes Are Associated With Left Ventricular Dysfunction in Patients With Type&#x02010;2 Diabetes Mellitus: A Two&#x02010;Dimensional Speckle Tracking Echocardiography Study</article-title>,&#x0201d; <source>Acta Cardiologica</source>
<volume>73</volume>, no. <issue>5</issue> (<year>2018</year>): <fpage>449</fpage>&#x02013;<lpage>456</lpage>.<pub-id pub-id-type="pmid">29216794</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="clc70153-cit-0059">
<string-name>
<given-names>A.</given-names>
<surname>Brand</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Romero Dorta</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Wolf</surname>
</string-name>, et al., &#x0201c;<article-title>Phasic Left Atrial Strain to Predict Worsening of Diastolic Function: Results From the Prospective Berlin Female Risk Evaluation Follow&#x02010;Up Trial</article-title>,&#x0201d; <source>Frontiers in Cardiovascular Medicine</source>
<volume>10</volume> (<year>2023</year>): <elocation-id>1070450</elocation-id>.<pub-id pub-id-type="pmid">36891246</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="clc70153-cit-0060">
<string-name>
<given-names>J.</given-names>
<surname>Cai</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Liang</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Feng</surname>
</string-name>, and <string-name>
<given-names>H.</given-names>
<surname>Long</surname>
</string-name>, &#x0201c;<article-title>Correlation Between Left Atrial Strain and Left Ventricular Diastolic Function in Hypertensive Patients</article-title>,&#x0201d; <source>Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University</source>
<volume>48</volume>, no. <issue>6</issue> (<year>2023</year>): <fpage>846</fpage>&#x02013;<lpage>851</lpage>.</mixed-citation></ref><ref id="clc70153-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="clc70153-cit-0061">
<string-name>
<given-names>E.</given-names>
<surname>Romero Dorta</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Wolf</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>H&#x000fc;bscher</surname>
</string-name>, et al., &#x0201c;<article-title>Impact of Body Mass Index on Worsening of Diastolic Function and Impairment of Left Atrial Strain in the General Female Urban Population: A Subanalysis of the Berlin Female Risk Evaluation Echocardiography Follow&#x02010;Up Study</article-title>,&#x0201d; <source>Frontiers in Cardiovascular Medicine</source>
<volume>10</volume> (<year>2023</year>): <elocation-id>1242805</elocation-id>.<pub-id pub-id-type="pmid">37799777</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="clc70153-cit-0062">
<string-name>
<given-names>J.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Xia</surname>
</string-name>, et al., &#x0201c;<article-title>Diastolic Dysfunction in Adults With Uncomplicated Obesity Evaluated With Left Atrial and Left Ventricular Tissue Tracking and Ventricular Volume&#x02010;Time Curve: A Prospective Cardiac Magnetic Resonance Study</article-title>,&#x0201d; <source>Quantitative Imaging in Medicine and Surgery</source>
<volume>14</volume>, no. <issue>7</issue> (<year>2024</year>): <fpage>5040</fpage>&#x02013;<lpage>5056</lpage>.<pub-id pub-id-type="pmid">39022235</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="clc70153-cit-0063">
<string-name>
<given-names>M.</given-names>
<surname>Barki</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Losito</surname>
</string-name>, <string-name>
<given-names>M. M.</given-names>
<surname>Caracciolo</surname>
</string-name>, et al., &#x0201c;<article-title>Left Atrial Strain in Acute Heart Failure: Clinical and Prognostic Insights</article-title>,&#x0201d; <source>European Heart Journal&#x02010;Cardiovascular Imaging</source>
<volume>25</volume>, no. <issue>3</issue> (<year>2024</year>): <fpage>315</fpage>&#x02013;<lpage>324</lpage>.<pub-id pub-id-type="pmid">37930715</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="clc70153-cit-0064">
<string-name>
<given-names>A.</given-names>
<surname>Hosseinsabet</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Mohseni&#x02010;Badalabadi</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Moinfar</surname>
</string-name>, &#x0201c;<article-title>Impaired Left Atrial Conduit Function in Coronary Artery Disease Patients With Poorly Controlled Diabetes: Two&#x02010;Dimensional Speckle&#x02010;Tracking Echocardiographic Study</article-title>,&#x0201d; <source>Journal of Ultrasound in Medicine</source>
<volume>36</volume>, no. <issue>1</issue> (<year>2017</year>): <fpage>13</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="pmid">27925659</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="clc70153-cit-0065">
<string-name>
<given-names>L.&#x02010;C.</given-names>
<surname>Benchea</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Anghel</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Z&#x00103;voi</surname>
</string-name>, et al., &#x0201c;<article-title>Beyond Blood Sugar: How Left Atrium Strain Predicts Cardiac Outcomes in Type 2 Diabetes</article-title>,&#x0201d; <source>Biomedicines</source>
<volume>12</volume>, no. <issue>8</issue> (<year>2024</year>): <fpage>1690</fpage>.<pub-id pub-id-type="pmid">39200155</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="clc70153-cit-0066">
<string-name>
<given-names>G.</given-names>
<surname>Mandoli</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Pastore</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Benfari</surname>
</string-name>, et al., &#x0201c;<article-title>Pathophysiologic Risk Stratification of Chronic Heart Failure: Coexisting Left Atrial and Right Ventricular Damage and the Role of Pulmonary Circulation</article-title>,&#x0201d; supplement, <source>European Heart Journal&#x02010;Cardiovascular Imaging</source>
<volume>22</volume>, no. <issue>S1</issue> (<year>2021</year>): <elocation-id>jeaa356. 180</elocation-id>.</mixed-citation></ref><ref id="clc70153-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="clc70153-cit-0067">
<string-name>
<given-names>S.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Cui</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Li</surname>
</string-name>, et al., &#x0201c;<article-title>Interaction Effect of Type 2 Diabetes Mellitus and Hypertension on Left Atrial Function: A Three&#x02010;Dimensional Echocardiography Study</article-title>,&#x0201d; <source>Quantitative Imaging in Medicine and Surgery</source>
<volume>13</volume>, no. <issue>12</issue> (<year>2023</year>): <fpage>8107</fpage>&#x02013;<lpage>8120</lpage>.<pub-id pub-id-type="pmid">38106252</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="clc70153-cit-0068">
<string-name>
<given-names>T. G.</given-names>
<surname>Utina</surname>
</string-name>, <string-name>
<given-names>D. U.</given-names>
<surname>Akasheva</surname>
</string-name>, <string-name>
<given-names>D. V.</given-names>
<surname>Korsunsky</surname>
</string-name>, and <string-name>
<given-names>O. M.</given-names>
<surname>Drapkina</surname>
</string-name>, &#x0201c;<article-title>Significance of Standard and Speckle&#x02010;Tracking Echocardiography for Early Diagnosis of Asymptomatic Left Ventricular Dysfunction in Type 2 Diabetes</article-title>,&#x0201d; <source>Cardiovascular Therapy and Prevention</source>
<volume>22</volume>, no. <issue>1</issue> (<year>2023</year>): <fpage>3478</fpage>.</mixed-citation></ref><ref id="clc70153-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="clc70153-cit-0069">
<string-name>
<given-names>L.</given-names>
<surname>Georgievska&#x02010;Ismail</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Zafirovska</surname>
</string-name>, and <string-name>
<given-names>Z.</given-names>
<surname>Hristovski</surname>
</string-name>, &#x0201c;<article-title>Evaluation of the Role of Left Atrial Strain Using Two&#x02010;Dimensional Speckle Tracking Echocardiography in Patients With Diabetes Mellitus and Heart Failure With Preserved Left Ventricular Ejection Fraction</article-title>,&#x0201d; <source>Diabetes and Vascular Disease Research</source>
<volume>13</volume>, no. <issue>6</issue> (<year>2016</year>): <fpage>384</fpage>&#x02013;<lpage>394</lpage>.<pub-id pub-id-type="pmid">27407084</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="clc70153-cit-0070">
<string-name>
<given-names>A.</given-names>
<surname>Goyal</surname>
</string-name>, <string-name>
<given-names>H. Q.</given-names>
<surname>Abbasi</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Yakkali</surname>
</string-name>, et al., &#x0201c;<article-title>Left Atrial Strain as a Predictor of Early Anthracycline&#x02010;Induced Chemotherapy&#x02010;Related Cardiac Dysfunction: A Pilot Systematic Review and Meta&#x02010;Analysis</article-title>,&#x0201d; <source>Journal of Clinical Medicine</source>
<volume>13</volume>, no. <issue>13</issue> (<year>2024</year>): <fpage>3904</fpage>.<pub-id pub-id-type="pmid">38999470</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="clc70153-cit-0071">
<string-name>
<given-names>Y.</given-names>
<surname>Su</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Li</surname>
</string-name>, and <string-name>
<given-names>L.</given-names>
<surname>Yin</surname>
</string-name>, &#x0201c;<article-title>Assessment the Predictive Value of Left Atrial Strain (LAS) on Exercise Tolerance in HCM Patients With E/e' Between 8 and 14 by Two&#x02010;Dimensional Speckle Tracking and Treadmill Stress Echocardiography</article-title>,&#x0201d; <source>Reviews in Cardiovascular Medicine</source>
<volume>24</volume>, no. <issue>6</issue> (<year>2023</year>): <fpage>167</fpage>.<pub-id pub-id-type="pmid">39077539</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="clc70153-cit-0072">
<string-name>
<given-names>E.</given-names>
<surname>Pilichowska&#x02010;Paszkiet</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Sikorska</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Kowalik</surname>
</string-name>, et al., &#x0201c;<article-title>Subclinical Dysfunction of Left Atrial Compliance After Cryoballoon Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation</article-title>,&#x0201d; <source>Journal of Clinical Medicine</source>
<volume>12</volume>, no. <issue>15</issue> (<year>2023</year>): <fpage>4974</fpage>.<pub-id pub-id-type="pmid">37568376</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="clc70153-cit-0073">
<string-name>
<given-names>Y.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Su</surname>
</string-name>, et al., &#x0201c;<article-title>Noninvasive Assessment of Left Atrial Phasic Function in Patients With Hypertension and Diabetes Using Two&#x02010;Dimensional Speckle Tracking and Volumetric Parameters</article-title>,&#x0201d; <source>Echocardiography</source>
<volume>31</volume>, no. <issue>6</issue> (<year>2014</year>): <fpage>727</fpage>&#x02013;<lpage>735</lpage>.<pub-id pub-id-type="pmid">24354465</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="clc70153-cit-0074">
<string-name>
<given-names>T. A.</given-names>
<surname>Ahmed</surname>
</string-name>, <string-name>
<given-names>Y. A.</given-names>
<surname>Ahmed</surname>
</string-name>, <string-name>
<given-names>A. I.</given-names>
<surname>Arafa</surname>
</string-name>, and <string-name>
<given-names>R. A.</given-names>
<surname>Salah</surname>
</string-name>, &#x0201c;<article-title>Detection of Occult Right Ventricular Dysfunction in Young Egyptians With Type 1 Diabetes Mellitus by Two&#x02010;Dimensional Speckle Tracking Echocardiography</article-title>,&#x0201d; <source>Indian Heart Journal</source>
<volume>70</volume>, no. <issue>5</issue> (<year>2018</year>): <fpage>665</fpage>&#x02013;<lpage>671</lpage>.<pub-id pub-id-type="pmid">30392504</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="clc70153-cit-0075">
<string-name>
<given-names>S.</given-names>
<surname>Rakha</surname>
</string-name> and <string-name>
<given-names>H. M.</given-names>
<surname>Aboelenin</surname>
</string-name>, &#x0201c;<article-title>Left Ventricular Functions in Pediatric Patients With Ten Years or More Type 1 Diabetes Mellitus: Conventional Echocardiography, Tissue Doppler, and Two&#x02010;Dimensional Speckle Tracking Study</article-title>,&#x0201d; <source>Pediatric Diabetes</source>
<volume>20</volume>, no. <issue>7</issue> (<year>2019</year>): <fpage>946</fpage>&#x02013;<lpage>954</lpage>.<pub-id pub-id-type="pmid">31355962</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="clc70153-cit-0076">
<string-name>
<given-names>H.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Chivese</surname>
</string-name>, et al., &#x0201c;<article-title>IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group's Criteria</article-title>,&#x0201d; <source>Diabetes Research and Clinical Practice</source>
<volume>183</volume> (<year>2022</year>): <elocation-id>109050</elocation-id>.<pub-id pub-id-type="pmid">34883186</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="clc70153-cit-0077">
<string-name>
<given-names>T.</given-names>
<surname>Mazumder</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Akter</surname>
</string-name>, <string-name>
<given-names>S. M.</given-names>
<surname>Rahman</surname>
</string-name>, <string-name>
<given-names>M. T.</given-names>
<surname>Islam</surname>
</string-name>, and <string-name>
<given-names>M. R.</given-names>
<surname>Talukder</surname>
</string-name>, &#x0201c;<article-title>Prevalence and Risk Factors of Gestational Diabetes Mellitus in Bangladesh: Findings From Demographic Health Survey 2017&#x02013;2018</article-title>,&#x0201d; <source>International Journal of Environmental Research and Public Health</source>
<volume>19</volume>, no. <issue>5</issue> (<year>2022</year>): <fpage>2583</fpage>.<pub-id pub-id-type="pmid">35270274</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="clc70153-cit-0078">
<string-name>
<given-names>W.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Liu</surname>
</string-name>, et al., &#x0201c;<article-title>Two&#x02010;Dimensional Speckle Tracking Echocardiography in Assessing the Subclinical Myocardial Dysfunction in Patients With Gestational Diabetes Mellitus</article-title>,&#x0201d; <source>Cardiovascular Ultrasound</source>
<volume>20</volume>, no. <issue>1</issue> (<year>2022</year>): <fpage>21</fpage>.<pub-id pub-id-type="pmid">35941651</pub-id>
</mixed-citation></ref><ref id="clc70153-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="clc70153-cit-0079">
<string-name>
<given-names>A.</given-names>
<surname>Sonaglioni</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Barlocci</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Adda</surname>
</string-name>, et al., &#x0201c;<article-title>The Impact of Short&#x02010;Term Hyperglycemia and Obesity on Biventricular and Biatrial Myocardial Function Assessed by Speckle Tracking Echocardiography in a Population of Women With Gestational Diabetes Mellitus</article-title>,&#x0201d; <source>Nutrition, Metabolism, and Cardiovascular Diseases</source>
<volume>32</volume>, no. <issue>2</issue> (<year>2022</year>): <fpage>456</fpage>&#x02013;<lpage>468</lpage>.</mixed-citation></ref></ref-list></back></article>